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ABSTRACT 
The metabolism of thymidine by Neurospora crassa was investigated 
a~er radioactive labeling experiments showed that thymidine is not 
specifically incorporated into the DNA of Neurospora; a finding in 
contrast to the results of labeled thymidine experiments with many 
other organisms. Labeling experiments in which 2-c14 deoxyuridine, 
2-c14 thymidine .and 2-c14 thymine were administered to Neurospora 
revealed that in each case ninety per cent of the nucleic acid label 
was in the RNA fraction. When thymidine methyl-H3 was administered 
no label was found in either the RNA or DNA. This and other evidence 
was taken as proof that Neurospora lacks phosphorylating enzymes for 
deoxyribose pyrimidine nucleosides but does possess enzymatic re-
actions by which these same compounds can be converted to RNA 
precursors. 
Three mutants were isolated in which different synthetic steps 
are blocked in the pathway that converts the pyrimidine ring of 
thymidine to an RNA precursor. Evidence from genetic studies, nutri-
tional tests and accumulation studies with the three mutant strains 
shows the pathway to proceed as follows: thymidine - thymine - 5-
hydroxymethyluracil - 5-formyluracil - uracil - uridylic acid. A 
mutant strain in which the thymidine to thymine conversion is pre-
vented is also unable to utilize deoxyuridine and deoxycytidine as 
pyrimidine sources and suggests a defective deoxyribose pyrimidine 
nucleosidase enzyme. A second mutation blocks the pathway at the 
5-hydroxymethyluracil to 5-formyluracil step and causes the accumulation 
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of thymine in the growth medium. The third mutation prevents the 
utilization of uracil and the compounds preceding it in the pathway. 
Three mutants were isolated in which the pyrimidine transport 
system was affected. One of these mutants could utilize the pyrimidine 
nucleosides (cytidine, uridine, deoxyuridine and thymidine) but could 
use none of the free bases (thymine, 5-hydroxymethyluracil, 5-formyl-
uracil and uracil). A second mutant could utilize the free bases but 
not the nucleosides. These results can be most simply interpreted in 
terms of the first mutation blocking a transport system specific for 
pyrimidine bases, and the second mutation blocking a system specific 
for the transport of pyrimidine nucleosides. A third mutation pre-
vented the utilization of both pyrimidine bases and nucleosides in a 
medium containing ammonium salts but permitted their use in a medium 
containing nitrate salts. 
A strain was isolated carrying a mutation which influences the 
regulation of the thymidine to RNA precursor pathway. This mutation 
allows the steps of the pathway that convert thymidine to uracil to 
f'unction in germinating conidia. A second mutation was found which 
suppresses the action of the first and restores the normal condition, 
the absence of the thymidine to uracil conversion in germinating 
conidia. 
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INTRODUCTION 
Thymidine metabolism 
Since the work of Taylor and associates (1) in 1957 the use of 
tritiated thymidine for the selective labeling of DNA (deoxyribonucleic 
acid) and chromosomes in autoradiographic studies has become widespread. 
The extensive use of such autoradiographic procedures has led to the 
premise that thymidine is specifically incorporated into DNA and that 
this is the only pathway of metabolism open to it other than complete 
degradation. However, scattered throughout the scientific literature 
are reports of the failure of labeled thymidine to label selectively 
the DNA of various species. 
Brachet (2) reported that the alga, Acetabularia mediterranea, 
incorporates a large portion of the radioactive label of c14-thymine 
and H3-thymidine into RNA (ribonucleic acid), specifically into uridylic 
and cytidylic acid. Stocking and Gifford (3) administered H3-thymidine 
to growing filaments of Spirogyra. Autoradiographs showed little 
labeling in the cell nucleus, but the chloroplast, which made up one-
third of the cell surface in contact with the film, contained ninety 
per cent of the total radioactivity. Meyer (4) confirmed these experi-
ments with Spirogyra and showed that the cytoplasmic label was not re-
moved by DNase, but that up to fifty per cent of the label was removed 
by RNase. Berech and van Wagtendonk (5) grew Paramecium aurelia in a 
medium containing H3-thymidine. Autoradiographs of organisms grown in 
the medium revealed marked labeling of the cytoplasm. Chromatography 
of the Paramecium cellular fractions showed that uridylic acid from the 
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RNA was radioactive. Baer and st. Lawrence (6) tried to use 
autoradiographic procedures to correlate DNA synthesis with chromosomal 
events in Neurospora crassa. They ,administered H3-thymine, thymidine-
methyl-H3 and H3-deoxyuridine in attempts to label specifically 
Neurospora DNA. The thymine and thymidine compounds yielded light 
labeling uniformly distributed over both the cytoplasm and nucleus. 
Deoxyuridine-H3 ·gave heavy labeling, but again the distribution of label 
over the cytoplasm and nucleus was the same. In summary it is clear 
that at least some organisms have a metabolic pathway capable of con-
verting thymidine to RNA precursors followed by incorporation into RNA. 
A metabolic pathway by which thymidine could be converted to RNA 
precursors was pointed out by Fink and Fink (7, 8, 9). They found that 
the radioactive labels of thymidine-2-c14, thymidine-5,6-c14 and 
uridine-2-c14 were all incorporated to a considerable extent into the 
nucleic acid fractions of Neurospora crassa. Further, the thymidine 
compounds gave labeling patterns similar to that of uridine in that 
there was eight to ten times more label in the RNA fractions than in 
the DNA fractions. When thymidine-methyl-H3 was administered no label 
was found in either the RNA or DNA fractions. These labeling experi-
ments led to three conclusions. 
1. Neurospora lacks a thymidine phosphorylating mechanism. 
2. The pyrimidine ring of thymidine is incorporated intact 
into an RNA precursor which can be used to form ribo-
nucleotides that are suitable for both RNA synthesis and 
for reduction to deoxyribonucleotides useable in DNA 
synthesis. 
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3. The conversion of thymidine into an RNA precursor occurs 
through the stepwise oxidation of the methyl group of 
thymine followed by elimination of the oxidized methyl 
group. 
Additional proof for the third conclusion was that chromatography of 
the early metabolic products of radiocarbon labeled thymidine resulted 
in the identification of labeled thymine, 5-hydroxymethyluracil and 
5-formyluracil (10). Crude enzyme preparations from rat liver (11) and 
Neurospora (12) have been shown to carry out the conversion of thymine 
to 5-hydroxymethyluracil. Possible intermediates of a pathway involving 
the stepwise oxidation of the thymine methyl group to yield an RNA 
precursor are given in the lower half of figure 1. 
Pyrimidine metabolism in Neurospora 
The general scheme of synthetic reactions involved in the formation 
of pyrimidines has emerged from research in many laboratories involving 
a variety of organisms (13). An abbreviated synthetic pathway including 
the sites of action of the pyrimidine (pyr) mutants of Neurospora is 
presented in the upper half of figure 1. Research which demonstrates 
that such a pathway operates in Neurospora includes that of Davis (14), 
who showed pyr-3a mutants were deficient in carbamyl phosphate synthesiz-
ing enzyme and pyr-3d mutants were deficient in aspartate transcarbamyl-
ase; Mitchell (15), who discovered the accumulation of erotic acid by 
pyr-2 and pyr-4 mutants, and Pynadeth and Fink (16), who proved the 
pyr-4 mutant lacks orotidylic acid decarboxylase activity. McNutt (17) 
grew a pyr-4 Neurospora mutant in a medium supplemented with uniformly 
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labeled c14-cytidine and found that the label was incorporated without 
dilution into the RNA and DNA pyrimidines. In addition the specific 
activities of the pyrimidine and sugar moieties of both the RNA and DNA 
pyrimidines were the same as those of the cytosine and ribose components 
of the initially administered cytidine. These results are consistent 
with the idea that deoxyribonucleotides are formed from ribonucleotides. 
Several int·eresting facts should be pointed out regarding utiliza-
tion of pyrimidines by Neurospora pyr mutants. Uridine and cytidine are 
the commonly used pyrimidine supplements for the mutants as the fungus 
apparently possesses an efficient phosphorylating enzyme for these 
ribonucleosides. Conversely, Neurospora is unable to phosphorylate 
orotidine (18), thymidine, deoxycytidine (9) and deoxyuridine (this 
thesis). The free pyrimidine bases, erotic acid, cytosine and uracil, 
are utilized very inefficiently by Neurospora in the standard growth 
media which contain ammonium salts. In a medium containing nitrate 
rather than ammonium salts uracil is used just as efficiently as uridine 
although cytosine and erotic acid are still poorly utilized. Thymidine, 
thymine and 5-hydroxymethyluracil alone will not support the growth of 
any pyr mutant but are utilized in the presence of uridine (10). Uptake 
experiments by Zalokar (19) showed that H3-uridine was rapidly taken 
into Neurospora mycelia. Column chromatography of the acid soluble 
mycelial components revealed all the radioactivity in two peaks corre-
sponding to two uridine diphosphate (UDP) sugar compounds. No activity 
was detected in free uridine or uridine mono-, di- and triphosphates. 
The UDP sugar compounds are probably uridine diphosphoglucose and uridine 
diphosphoacetylglucosea.mine (20). 
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Possible additional pyrimidine mutants of Neurospora 
Examples of two classes of reactions for which nutritional mutants 
are seldom recovered are shown in figure 1. The first class includes 
those reactions involving phosphorylated intermediates to which the cell 
membrane is impermeable. Nutritional mutants involving reactions of 
phosphorylated compounds can be recovered only if the required parent 
organic compound ·can enter the cell and be phosphorylated within the 
cell. For example, the pyr-4 mutant was recovered because uridine could 
be phosphorylated. A mutant blocking the deoxyuridylic acid to 
thymidylic acid step cannot be recovered in Neurospora because Neurospora 
cannot phosphorylate thymidine. 
A second and largely untouched class of Neurospora mutants are 
those which go undetected because they do not affect essential reactions. 
Reactions involving salvage pathways such as exist for purines, pyrimi-
dines and aromatic compounds are of this class. As an example, a muta-
tion blocking the conversion of thymidine to an RNA precursor would not 
normally be detected because Neurospora can synthesize de ~ suffi-
cient pyrimidines for normal growth. Only when the de ~ synthetic 
pathway is blocked does the salvage pathway become essential and does a 
means for selecting mutants of the salvage pathway become available. 
The purpose of this research was to investigate methods by which the 
specific labeling of Neurospora DNA might be brought about, to devise 
procedures which would yield mutants of the pyrimidine salvage pathways 
(specifically the pathway by which thymidine is converted to an RNA 
precursor) and to use these mutants to elucidate further the steps in 
the pathway. 
7 
MATERIALS AND METHODS 
Neurospora strains 
Wild type strains 4~ and 25~, three pyrimidine (pyr) mutants and 
one purine (ad-6) mutant were used. The mutants were kindly provided 
by Mary B. Mitchell from the Neurospora stocks of the Caltech Division 
of Biology. A brief description of the mutants used, including isola-
tion number, mating type, linkage group and step in the synthetic path-
way blocked by the mutation is as follows. Pyr-3 (31301~, linkage 
group IV R) lacks aspartate transcarbamylase enzyme activity (21, 22). 
Pyr-1 (H263~, linkage group IV R) is blocked in the pyrimidine 
synthetic pathway between ureidosuccinic acid and orotic acid (21, 22). 
Pyr-4 (36601~, linkage group II L) has no orotidylic acid decarboxylase 
activity (23, 16). The pyr-4 mutant releases large amounts of orotic 
acid into the growth medium (15). Orotic acid gives strong absorption 
in the ultraviolet portion of the spectrum and has an ab.sorption maxi-
mum at 280 mµ in dilute acid. Neither pyr-1 nor pyr-3 mutants release 
accumulated compounds into the growth medium. The ad-6 mutation 
(28610~, linkage group IV R) causes the purine synthetic pathway to be 
blocked at an early stage, before closure of the imidazole ring (21, 24). 
Source of pyrimidines 
The four radioactive labeled pyrimidines which were used in 
experiments with pyrimidine mutants are as follows: 2-c14 thymidine 
(30 mcurie/rrunole--New England Nuclear Corp.), 2-c14 thymine (45 mcurie/ 
mmole--New England Nuclear Corp.), 2-c14 deoxyuridine (23 mcurie/mmole--
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California Corporation for Biochemical Research) and thymidine-methyl-H3 
(6100 mcurie/nnnole--Schwarz Bioresearch Inc.). The large number of 
nonlabeled purine and pyrimidine compounds used in the classification 
of various mutants affecting pyrimidine metabolism came from the follow-
ing sources: thymidine, 5-hydroxymethyluracil, uridine, cytidine and 
cytosine (California Corporation for Biochemical Research); thymine, 
uracil and adenosine (Sigma Chemical Company); uracil-5-carboxylic acid 
(K & K Laboratories); deoxyuridine, deoxycytidine, deoxyadenosine and 
deoxyguanosine (Nutritional Biochemicals Corporation). Two compounds, 
5-fluorodeoxyuridine and 5-formyluracil could not be obtained commer-
cially. The 5-fluorodeoxyuridine was obtained from Dr. R. Duschinsky 
of Hoffman-La Roche Inc. while 5-forrnyluracil was synthesized. 
The procedure of Fink et al. (25) was followed for the synthesis 
of 5-forrnyluracil from 5-hyd.roxymethyluracil by using oxygen and a 
platinum catalyst. Their procedure was an adaptation of the method 
proposed by Sneeden and Turner (26) for the dehydrogenation of primary 
alcohols to yield aldehydes. 
A suspension of platinum oxide (75 mg in 6 ml of 50% acetic acid) 
was first reduced to platinum in an atmosphere of hydrogen (in Parr 
apparatus for 75 minutes at 40 pounds H2 pressure) a~er which the 
hydrogen was removed and replaced with air. Oxygen gas was then slowly 
bubbled into the suspension for 30 minutes followed by the addition of 
12 mg of 5-hydroxymethyluracil which slowly dissolved in the acetic 
acid. The oxygen was allowed to bubble slowly into the suspension for 
18 hours a~er which the acetic acid solution was removed from the 
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platinum catalyst and evaporated in an air stream. The products were 
redissolved in water and separated on a Dowex-50 ion exchange column 
(separation is discussed in the following section). A yield of 80% 
5-formyluracil was attained with the remaining 20% consisting of 
5-hydroxymethyluracil (15%) and uracil-5-carboxylic acid (5%). 
The criteria used in assuming that the 80% yield product was 
5-fo:rmyluracil were its chromatographic behavior, its UV absorption 
spectra in acid and base and the growth response, or lack of response, 
of mutants in the thymine-methyl oxidative pathway to the product. 
Using ascending paper chromatography the location of the synthesized 
5-formyluracil af'ter development in each of two solvent systems, t-butyl 
alcohol, methyl ethyl ketone, H20 and NH4oH (40:30:20:10) and ethyl 
acetate, formic acid and H20 (70:20:10), was the same as reported for 
5-formyluracil (27). The maximum and minimum wavelengths of ultra-
violet absorption reported for 5-formyluracil (25) and those obtained 
from the 5-formyluracil synthesized in 80% yield are given below. 
Compound pH max. (mµ) min. (mµ) 
5-formyluracil 2 275.5 248 
80% yield product 2 275 248 
5-formyluracil 12 298 267 
80% yield product 12 298 268 
Ion exchange chromatography of pyrimidines 
Wall (28) reported that uracil and thymine could be separated on a 
column of Dowex-50 resin by eluting with 1.5 N HCl. Further work with 
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the Dowex-50 column revealed that it could be used to separate several 
5-substituted pyrimidines which were not tried by Wall. An additional 
finding was that water would elute these pyrimidines from the Dowex-50 
column and would elute them in a somewhat different order than HCl. 
Dowex-50-X8, 200 to 400 mesh resin was cleaned by the following 
procedure: two washes with hot 6 N HCl, two washes with water, two 
washes with 1 N·NaOH, two washes with 1.5 N·Hcl and two washes with 
water. The cleaned resin was suspended in H2o and poured as a slurry 
into a glass chromatography tube to form a column 1.3 cm in diameter 
and 50 cm in height. Water or 1.5 N HCl was washed through the column 
for 24 hours before its use to reduce to a low level the background of 
UV absorbing material coming from the resin. 
. 
The ion exchange column was used to aid in the identification and 
purification of pyrimidines accumulated in the growth mediwn by certain 
mutants and for separation of 5-formyluracil from a synthetic reaction 
mixture. A volume of 0.5 to 2.0 ml of used medium or reaction mixture 
(acidified if 1.5 N HCl was to be eluant) containing two to seven 
µmoles of pyrimidine was added to the top of the column and washed into 
the resin with two ml of H20 or 1.5 N HCl. Elution was then started 
at a flow rate of about 15 ml per hour. Fractions of volume 1.5 to 2.0 
ml were collected and their absorptions at 265 mµ were measured with a 
model 15 Cary spectrophotometer. 
The identity of a pyrimidine compound eluted from the column could 
generally be determined by the location and characteristic lN absorption 
spectrum of the fractions containing the compound. The concentration of 
ll 
pyrDnidine in a fraction was calculated from its O.D. 265 above 
background in relation to the O.D. 265 of a known concentration of that 
pyrimidine. The amount of each pyrimidine added to the column could 
be determined from its concentration per fraction and the measured 
volume of the fractions. 
The effluent volumes of 0.35 µmole amounts of various pyrimidines 
added to a 1.3 X 50 cm Dowex-50-X8 column are shown below. Data with 
both H20 and 1.5 N HCl eluant are given as well as wavelength of maximum 
absorption in 1.5 N HCl . 
Effluent Volume 
Pyrimidine max. ~m~l HCl eluant H20 eluant 
uridine 261 30 - 35 ml 29 - 35 ml 
5-CH20H uracil 260 35 - 40 ml 38 - 44 ml 
thymidine 266 40 45 ml 
uracil 258 46 - 50 ml 51 - 57 ml 
5-formyluracil 275 46 - 50 ml 51 - 57 ml 
5-carboxyuracil 272 46 - 50 ml 29 - 35 ml 
thymine 264 62 - 70 ml 67 - 75 ml 
RNA and DNA extraction 
The method used for extraction of RNA and DNA from Neurospora was 
developed by Dr. H. K. Mitchell (unpublished data). The method is an 
adaptation of the perchloric acid extraction procedure described by 
Ogur and Rosen ( 29) • 
Wet mold was placed in a Buchner f'unnel where the growth medium was 
removed by rinsing with water and by gentle suction. The pad was then 
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put in a beaker and alcohol and ether soluble substances were extracted 
by three changes of absolute ethanol, followed by three changes of a 
one to one mixture of absolute ethanol and ethyl ether and finally by 
three changes of ethyl ether. Approximately 20 parts of solvent per 
gram of mold (wet weight) were used in each solvent change. The ether 
dry mold was ground and a 250 mg portion was mixed with 5.0 ml of cold 
0 1.0 M HClo4 and ·let stand 12 hours at 0 c. The mixture was then centri-
fuged, the supernatant removed and the residue reextracted by cold 
Hc104 in the same way a total of five times. The cold Hclo4 extract 
contained essentially all the RNA in a partially degraded form. The 
residue from the RNA extraction was extracted three times at 75°c for 
fif'teen minutes with 5.0 ml portions of 1.0 M HClo4• This treatment 
partially degraded and made soluble all the DNA. 
The RNA concentrations of the cold HClo4 extracts were determined 
by their optical density at 260 mµ in relation to yeast RNA standards. 
A second measure of RNA concentration was made by using Bial's reagent 
(orcinol, Fec13 and 30% HCl) to test for pentose (29). Conditions for 
the photocolorimetric estimation of pentose are as follows. Two ml 
Bial's reagent plus three ml of l N HCl04 containing the RNA were mixed, 
heated 20 minutes in a boiling water bath, allowed to stand eight hours 
and then centrifuged to remove interfering material. The optical 
density at 666 mµ was then compared with that of yeast RNA standards 
that had been treated in a similar manner. 
Heating DNA in 1 N HClo4 at 75°c for 15 minutes causes a shif't in 
the UV absorption maximum from 260 to 268 mµ. Therefore, the DNA 
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concentrations of the hot HClo4 extracts were determined by their 
optical density at 268 mµ in relation to DNA standards that had also 
been heated in HC104. As a second measure of DNA concentration the 
diphenylamine photocolorimetric test (30) for deoxypentose was used. 
Two ml of the diphenylamine reagent and one ml of the l N HC104 DNA 
solution were mixed and allowed to incubate at room temperature for 16 
to 20 hours. The optical density of the reaction mixtures were read 
at 600 mµ. 
Radioactive labeling procedures 
In experiments where radioactive labeling was used the ether dry 
pad was placed in cold Hc104 and then ground. Frequently the dry weight 
of labeled mycelia to be extracted was less than 250 mg. In these 
cases extraction volumes were reduced proportionately. The perchloric 
acid RNA and DNA extracts were neutralized at o0 c with KOH. Approxi-
mately 80% of the resulting Kc104 salt precipitated from solution and 
was discarded. In c14 labeling experiments 0.01 to 0.05 ml aliquots of 
the growth medium at the start, used growth medium, alcohol extract, 
ether extract and neutralized HC104 extracts were applied directly to 
aluminum planchets and counted on a Nuclear Chicago low background 
counter . Each extract or medium was applied to three planchets, and the 
resulting counts per minute were averaged. The degree of variation 
involved in the extraction and counting procedure permits an error of 
+ 5% in the total counts reported for the various extracts. 
In H3 labeling experiments 0.025 ml aliquots of the extract or me-
dium to be counted were placed in 20 ml glass vials and 10 ml of Bray's 
14 
solution (70) was added to each vial. Af'ter allowing time for the 
samples to equilibrate to the temperature of the counter, they were 
counted in a Nuclear Chicago Scintillation Counter (720 Series). The 
efficiency pf counting in each sample was determined by the channels 
ratio method. 
Growth media and conditions 
The growth responses of mutant strains to various pyrimidines were 
measured in terms of the dry weight of the mycelia. The mold was cul-
tured in 25 ml of medium contained in 125 ml Erlenmeyer flasks for five 
to six days at 25°c. Af'ter two days of growth in standing culture the 
flasks were placed on a shaker for the remainder of the growth period. 
The mycelial pads were removed, dried at 65 - 70°c for at least 10 
hours and weighed. When this procedure was used and two flasks con-
taining the same mutant inoculum and the same concentration of growth 
limiting pyrimidine were grown side by side the dry weights of the re-
sulting pads were almost always within 10% of one another. Unless 
otherwise stated the medium used for growth tests was Westergaard-
Mi tchell medium (contains nitrate but no ammonium nitrogen) (31) at an 
unadjusted pH of 4.5. In a few cases the standard Fries medium was · 
used (contains ammonium salts) (32). The trace element solution used 
was that of Vogel (33). Mutant strains were maintained on agar slants 
of either Horowitz complete medium (34) or Westergaard-Mitchell medium 
supplemented with pyrimidines. 
Mutant production 
All the new mutants to be reported were induced by ultraviolet 
15 
radiation. The procedure was the same in all cases, the only variations 
being the strain and concentration of conidia that received the 
irradiation and the length of exposure to the ultraviolet light. All 
the strains used possessed multinucleate conidia. 
Conidia from strains grown on complete medium agar slants were sus-
pended in sterile H20 and the resulting suspension was twice filtered 
through glass wo·oi. An estimate of conidia concentration was made by 
determining the optical density of the suspension in a Klett-Summerson 
colorimeter. With a filter of spectral range 400 to 465 mµ one Klett 
unit equaled approximately 50,000 conidia per ml. The conidial suspen-
sion was then diluted to a concentration of from l X 106 to 4 X 106 
conidia per ml and 10 ml of the diluted conidial suspension was placed 
in a 100 X 15 mm Petri dish. The open Petri dish was placed under an 
ultraviolet lamp with a maximum emission at 254.7 mµ (model UV-30 lamp 
manufactured by the American Sterilizer Co.). The conidial suspension, 
which was shaken continually during exposure, was 7.5 cm from the ultra-
violet light bulb. The time of ultraviolet exposure ranged from 30 
seconds to two minutes depending on the strain irradiated and the degree 
of killing desired. Samples of conidia were applied to sorbose plates 
immediately before and after exposure to UV light in order to determine 
the per cent of killing. 
The degree of killing desired was such that the majority of sur-
viving conidia would have only one Viable nucleus. Thus, if a mutation 
occurred in one of these nuclei, the effect of the mutation could not be 
masked by the presence of a normal nucleus. A commonly used per cent of 
16 
kill in mutant hunts involving macroconidial strains is 90 to 993. In 
these experiments such a killing range was tried, but was found un-
desirable for two reasons: (1) a large ntunber of the isolated colonies 
grew very slowly, often not producing enough mycelia to inoculate a 
series of flasks; (2) no mutants of the desired type were found. Much 
better success was achieved when conidia were exposed to UV light until 
only 40 to 60% were killed. 
Filtration enrichment method 
The filtration enrichment method is f'requently used for isolation 
of specific nutritional mutants in Neurospora (35, 36, 37). The method 
works especially well for finding mutants which require a considerable 
amount of growth factor to give appreciable growth. In the procedure 
conidia which have been exposed to mutagen are grown in a liquid 
minimal medium. By repeated filtering through some type of sterile 
filter, germinated conidia are removed. Conidia which have undergone 
mutation so that they cannot manufacture some growth factor tend not 
to germinate and to pass through the filter. Thus, the medium is en-
riched in mutant conidia. The conidia remaining after several filtra-
tions are inoculated onto agar medium supplemented with the growth 
factors for which nutritional mutants are sought. 
In these experiments the approach was somewhat different in that 
mutants were desired that block various steps in pyrimidine salvage 
pathways. In order to observe the presence or absence of the salvage 
pathways by growth tests the normal pyrimidine synthetic pathway must 
be blocked. Therefore, instead of wild type a pyrimidine mutant was 
17 
used as the source of conidia. In place of minimal medium the 
filtration enrichment medium was supplemented with a pyrimidine com-
pound. The selection was then for mutants which could not use the 
pyrimidine supplement in the enrichment medium, but could use whatever 
pyrimidine supplement was added to the medium onto which surviving 
conidia were inoculated. 
Af'ter UV irradiation 2.5 ml of the 4 X 106 conidia/ml suspension 
was inoculated into a 250 ml Erlenmeyer flask containing 50 ml of 
medium supplemented with two to three µmoles of the pyrimidine for 
which nutritional mutants were desired. The conidia were kept in sus-
pension by placing the flask on a rotary shaker. Whenever mycelia 
became visible the contents of the flask were filtered into a second 
flask through a thistle tube containing a layer of glass wool. The 
amount of glass wool was·such that the flow of conidial suspension 
through it was only slightly impeded. The time of incubation in the 
enrichment medium before the final filtration and subsequent inoculation 
of sorbose plates was 48 to 72 hours. The total number of filtrations 
required was seven to eight; the first at five to ten hours followed by 
four or five more filtrations within the next 24 hours. 
Sorbose plates 
Immediately af'ter UV irradiation or following the filtration enrich-
ment procedure conidia were spread onto agar plates containing sorbose. 
A combination of a reduction in sucrose concentration to 0.1 - 0.2% and 
addition of 1.0 to 1.5% L-sorbose to the medium causes each germinating 
conidium to produce mycelium that is colonial in growth habit (38). 
18 
The sterilized sorbose medium was poured into sterile plastic 15 X 
100 mm Petri dishes. Each dish contained 25 ml Westergaard-Mitchell 
medium (normal concentration of salts, trace elements and biotin), 0.2% 
sucrose, 1.5% sorbose, 2.0% agar and various pyrimidine supplements de-
pending on the type mutant being selected for. For purposes of brevity 
the above Petri dishes and their contents will be referred to only as 
sorbose plates containing a given kind and concentration of pyrimidine. 
Colonial growth on sorbose plates 
Depending on the concentration of viable conidia O.l to 1.0 ml of 
conidial suspension was added to each sorbose plate and spread over the 
surface with a glass rod. The inoculated sorbose plates were kept at 
25°c. At two to three and one-half days a~er inoculation colonies be-
came easily visible to the naked eye. Beginning at this stage the 
colonies grew quite rapidly and within an additional 24 to 36 hours 
would produce aerial hyphae and form conidia. Therefore, with one ex-
ception (to be discussed under the section describing the isolation of 
the pyr-4 uc-2 double mutant), all colonies were removed from the sor-
bose plates as soon as they became readily visible and were transferred 
to either complete medium agar tubes or crossing medium agar tubes with 
a uridine supplement. 
A characteristic of UV irradiation is that it slows the germination 
and initial growth of many conidia. The first colonies appeared on the 
sorbose plates at two and one-half to three days, but a few colonies 
were still arising at seven days after inoculation. For this reason 
the sorbose plates were scanned and newly appearing colonies removed 
19 
every 24 hours over a period of four or five days. This repeated 
scanning and removal of colonies was very important since a large 
majority of the colonies picked up were not mutant and those mutants 
that were found were frequently not isolated until the fi~h to 
seventh day a~er inoculation. 
Introduction 
20 
PYR-4 MUTANT 
Fink and Fink reported that thymidine, thymine, uracil-5-carboxylic 
acid and 5-hydroxymethyluracil have a sparing action for uridine when 
uridine is present in amounts suboptimal for the growth of the pyr-4 
mutant (7, 10). Further, the radioactive labels of pyrimidine ring 
labeled thymidine, thymine and 5-hydroxymethyluracil were incorporated 
into RNA and DNA in such a manner that both nucleic acids had the same 
specific activity (9, 10). When the radioactive label was in the 
5-methyl position of thymine or thymidine no label was found in the RNA 
and DNA at all. Their conditions for these experiments were a standard 
Fries medium, a growth limiting concentration of uridine and an equal 
concentration of some labeled pyrimidine. Experiments were pursued to 
verify the above results and to determine if feeding a labeled pyrimi-
dine under other growth conditions could result in DNA with a higher 
specific activity than RNA. 
Effect of growth medium 
An initial discovery was that thymidine, thymine and 5-hydroxy-
methyluracil had a much larger sparing action for uridine in 
Westergaard-Mitchell medium than in the standard Fries medium. For 
this reason growth experiments involving the ~ mutants and selection 
procedures for mutants affecting pyrimidine salvage pathways were 
carried out in Westergaard-Mitchell medium rather than Fries. The 
sparing actions of thymidine and uracil-5-carboxylic acid for uridine 
in the two growth media are shown in Table 1. Of the intermediates 
21 
Table 1.--Effect of growth medium on utilization of uracil-5-carboxylic 
acid and thymidine by pyr-4 mutant. 
Pyrimidine Supplement 
µmoles/flask 
0.5 uridine 
0.5 uridine + 0.5 thymidine 
0.5 uridine + 1.5 thymidine 
2.0 uridine 
2.0 uridine + 0.5 thymidine 
2.0 uridine + 1.5 thymidine 
LO uridine 
l.O uridine + 1.0 5-COOH uracilg/ 
1.0 uridine + 3.0 5-COOH uracil 
1.0 uridine + 9.0 5-COOH uracil 
1.5 thymidine 
3.0 5-COOH uracil 
Fries 
medium 
13.4 
16.6 
16.7 
37 .5 
41.0 
42.8 
22.6 
24.l 
25.3 
0 
0 
Dry wt. (mgl of Pad!?' 
Westergaard-
Mitchell medium 
9.1 
21.5 
32.4 
30.1 
43.8 
67 .3 
17 .5 
18.o 
18.4 
19.5 
0 
0 
!/Each figure is the average weight of three pads. Time of growth--
5 days • 
.s'uracil-5-carboxylic acid 
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which could possibly be found in the thymine-5-methyl oxidative 
pathway (5-cH3, 5-CH20H, 5-CHO and 5-COOH) only uracil-5-carboxylic 
acid failed to give a large sparing action for uridine on West~rgaard-
Mitchell medium. 
Nucleic acid extraction procedure 
Experiments to show the effectiveness of the RNA and DNA extraction 
procedure and to determine the nucleic acid content of three strains of 
Neurospora grown for various lengths of time in two different media are 
given in Table 2. The reliability of both the extraction procedure in 
separating RNA from DNA and of the calculation of nucleic acid concen-
tration from the UV absorption of the extracts was confirmed by RNA and 
DNA concentration measurements based on Pentose (Bial's reagent) and 
deoxypentose (diphenylamine reagent) content of the extracts. An in-
teresting difference noted between mycelial pads grown in the two 
different media was that the RNA and DNA content of Neurospora grown 
\ 
in Fries medium was always higher than Neurospora grown for the same 
length of time in Westergaard-Mitchell medium. 
2-c14 thymine label 
The pyr-4 mutant was grown in three types of media containing 
2-c14 thymine as reported in Table 3. Three observations were made 
from this experiment. (1) A high proportion of label was found in 
the nucleic acid extracts--about 85% when the Neurospora was grown in 
Westergaard-Mitchell medium and about 50% when the Neurospora was 
grown in Fries medium. (2) A great majority (85 to 90%) of the nucleic 
acid label was found in the RNA fraction. (3) Changes in the growth 
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14 Table 3.--Utilization and distribution of 2-C thymine label by pyr-4 
mutant grown in three types of media. 
CPM in Growth Medium and Pad Extracts 
Solution Counted w.-M.Y FriesY Fries]} 
limiting ud. 
Growth medium at start 2,479,000 
Growth medium at 4 1/2 days 233,000 
Alcohol extracts · · 38, 000 
Alcohol-ether and ether 
extracts 500 
RNA extracts 1,869,000 
DNA extracts 257,000 
Per cent of label 
accounted for a~er 
4 1/2 days growth 
Per cent of label at zero 
time found in RNA and 
DNA at 4 1/2 days 
Per cent of total nucleic 
acid counts due to DNA 
97% 
86% 
14°/o 
limiting ud. 
2,479,000 
1,009,000 
21,000 
1,500 
998,000 
113,000 
86°/o 
10°/o 
excess ud. 
1,240,000 
559,000 
14;000 
1,000 
595,000 
76,000 
100°/o 
54% 
11°/o 
!/Limiting uridine Westergaard-Mitchell medium--Two flasks each contain-
ing 25 ml of Westergaard-Mitchell mediUm + 1.0 µmole of uridine + 0.045 
µmole of 2-cl4 thymine (1 µcurie) were inoculated with pyr-4 and grown 
for 4 1/2 days. The resulting two pads were pooled (dry wt. 58 mg) and 
extracted. 
g/Limiting uridine Fries medium--Two flasks each containing 25 ml of 
Fries medium + 1.0 µmole of uridine + 0.045 µmole of 2-cl4 thymine 
(1 µcurie) were inoculated with pyr-4 and grown for 4 1/2 days. The 
resulting two pads were pooled (dry wt. 72 mg) and extracted. 
lf Excess uridine Fries medium--One flask containing 25 ml of Fries + 5.0 
µmoles of uridine + 0.045 µmole of 2-cl4 thymine was inoculated with 
pyr-4 and grown for 4 1/2 days. The resulting pad (dry wt. 79 mg) was 
then extracted. 
25 
medium and alterations of the uridine-thymidine ratio did not cause the 
ratio of label in RNA to label in DNA to change significantly. 
2-c14 deoxyuridine label 
This experiment, the details of which are given in Table 4, was 
similar to the one just described except that 2-c14 deoxyuridine was 
the labeled compound and a wild type strain was used in addition to the 
pyr-4 mutant. One-half or more of the label initially present in the 
growth medium was found in the nucleic acid extracts of both pyr-4 and 
wild type strains. In each case approximately 90% of the nucleic acid 
counts were found in the RNA and only about 10% were in the DNA extract. 
Thymidine-methyl-H3 label 
When pyr-3 and pyr-4 mutants were grown in media containing thymi-
dine labeled in.the 5-methyl position the amount of label found in the 
nucleic acid extracts was negligible (Table 5). At the end of the 
incubation period all the label still remained in the growth media 
although one-fourth to one-half of the H3 was in a volatile form, pre-
sumably water, indicating that at least this much of the thymidine had 
been metabolized. If Neurospora had a thymidine phosphorylating 
enzyme, use of 5-methyl labeled thymidine would provide a way of speci-
fically labeling DNA even in the presence of a pathway converting the 
pyrimidine ring of thymidine to RNA precursors. The labeling experi-
ments clearly indicate that Neurospora does not have thymidine, deoxy-
uridine and thymine phosphorylating mechanisms, but does have an 
efficient system for salvaging the pyrimidine ring of these compounds 
for use in both RNA and DNA synthesis. 
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Table 4.--Utilization and distribution of 2-c14 deoxyuridine label by 
pyr-4 and wild type strains. 
CPM in Growth Medium and Pad Extracts 
Solution Counted 
Growth medium at start 
Growth medium at 5 days 
Alcohol extracts 
Alcohol ether and ether 
extracts 
RNA extracts 
DNA extracts 
Per cent of label accounted 
for a~er 5 days growth 
Per cent of label at zero 
time found in RNA and DNA 
at 5 days 
Per cent of total nucleic 
acid counts due to DNA 
pyr-4 
Fr~:Y 
me di 
863,000 
196,000 
10,000 
500 
521,000 
52,000 
90% 
66°/o 
pyr-4 wild 
w.-M. I 
medium.£ 
w.-M. I 
medium-3. 
863,000 762,000 
21,000 25,000 
3,000 29,000 
500 2,000 
334,000 435,000 
46,ooo 43,000 
47°/o 101o · 
44°/o 
12°/o 9°/o 
~Limiting uridine Fries medium--Two flasks each containing 25 ml of 
Fries medium + 1.0 µmole of uridine + 0.022 µmole of 2-cl4 deoxyuridine 
(0.5 µcurie) were inoculated with pyr-4 and grown for five days. The 
resulting two pads were pooled (dry wt. 54 mg) and extracted. 
g/Limiting uridine Westergaard-Mitchell medium--Two flasks each con-
taining 25 ml of Westergaard-Mitchell medium + 1.0 µmole of uridine + 
0.022 µmole of 2-cl4 deoxyuridine (0.5 µcurie) were inoculated with 
pyr-4 and grovm for five days. The resulting two pads were pooled 
(dry wt. 32 mg) and extracted. 
llone flask containing 25 ml of Westergaard-Mitchell medium + 0.022 
µmole of 2-cl4 deo.xyuridine (0.5 µcurie) was inoculated with wild 
type and grown for five days. The resulting pad (dry wt. 75 mg) was 
then extracted. 
Table 5.--Utilization and distribution of thymidine-methyl-H3 by pyr-3 
and pyr-4 mutants grown in Fries and Westergaard-Mitchell 
medium. 
Medium or Extract Counted 
w.-M. medium at start 
Fries medium at start 
w.-M. medium (pyr..:4) at 92 hours 
w.-M. medium (pyr-3) at 92 hours 
Fries medium (pyr-4) at 92 hours 
Fries medium (pyr-3) at 92 hours 
RNA extract of pyr-4 grown on w.-M. 
RNA extract of pyr-3 grown on w.-M. 
RNA extract of pyr-4 grown on Fries 
RNA extract of pyr-3 grown on Fries 
DNA extract of pyr-4 grown on w.-M. 
DNA extract of pyr-3 grown on W.-M. 
DNA extract of pyr-4 grown on Fries 
DNA extract of pyr-3 grown on Fries 
DPM in Medium or Extract 
DPM in Medium at Start 
100% 
100% 
100% 
105% 
100% 
105% 
0.39% 
0.51% 
0.46% 
0.46% 
0.10% 
0.16% 
0.06% 
0.06% 
(47,490,000 DPM) 
( 47, 300, 000 DPM) 
511):/ 
54% 
76% 
72% 
!/This column represents radioactivity remaining after volatile 
components of the used medium were evaporated away. 
Four flasks were prepared (two with 25 ml of Westergaard-Mitchell 
medium and two with 25 ml of Fries medium) each containing 5.0 µmoles 
of uridine and 0.0033 µmole of thymidine-methyl-H3 (20 µcuries). Pyr-4 
and pyr-3 conidia were inoculated into one flask of each type medium 
and grown for 92 hours on a shaker. · Dry weights and nucleic acid con-
tents of nonlabeled controls grown at the same time are as follows. 
Mutant Medium Dry Wt./Flask RNA (mg/g) DNA (mg/g) 
pyr-4 W.-M. 35 mg 55.2 3.26 
pyr-3 W.-M. 44 mg 47 .5 3.21 
pyr-4 Fries 59 mg 62.0 4.64 
pyr-3 Fries 66 mg 60.0 4.68 
28 
PYR-4 ~ DOUBLE MUTANT 
Selection of mutant 
The pyr-4 mutant, like the other pyrimidine mutants will not grow 
at all when thymidine, thymine or 5-hydroxymethyluracil are the sole 
pyrimidine sources. However, in Westergaard-Mitchell medium containing 
limiting amounts of uracil, uridine, or cytidine added thymidine, 
thymine, or 5-hydroxymethyluracil supplements show a large sparing 
action. Since a pathway for utilization of these compounds obviously 
existed an attempt was made to find mutants which would use the com-
pounds as their sole pyrimidine sources. Since such mutants would have 
activity that the normal pyr-4 mutant did not have large numbers of 
conidia could be screened. 
A 4 X 106 conidia/ml suspension of pyr-4 conidia was given UV 
irradiation for one minute (50% kill) and 400,000 conidia were inocu-
lated onto each of 44 sorbose plates containing 0.75 µmole of thymidine 
plus 0.75 µmole of thymine per 100 ml. Fiftynine colonies appeared and 
were transferred to Westergaard-Mitchell medium plus uridine, agar 
tubes. In testing the isolates 54 were found to grow on minimal medium 
and were probably pyr-4 revertants or pyr-4 suppressor mutants. Five 
isolates did not grow on minimal medium, but did grow on crossing medium 
with only a thymine or thymidine supplement as shown in Table 6. The 
new mutation present in these isolates was given the designation 
uracil-1, abbreviated uc-1. 
Cross to wild type 
Only one isolate, Pyr-4 uc-1 #57 was chosen for further work. The 
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mutant was crossed to wild type 4~; asci were dissected; and the 
genotypes of the spore pairs were determined by growth tests in minimal 
medium and in medium supplemented with thymine and thymidine. Pyr-4 
mutants could not grow in either medium; pyr-4 uc-1 mutants could grow 
in the supplemented but not the minimal medium. Wild or uc-1 mutants 
grew pro:f'usely in both growth media. By growth tests it was not possi-
ble to determine · the difference between a wild or uc-1 strain. The 
data in Table 7 suggest that the pyr-4 and ~ loci are linked, al-
though not closely. However, in two later crosses where one parent 
was a pyr-4 uc-1 mutant reisolated from the above cross, there was no 
recombination between the pyr-4 and uc-1 loci. 
Growth tests 
A pyr-4 uc-1 strain selected from those isolated in the cross of 
pyr-4 uc-1 #57 X 4~ was used in the growth response experiment, as well 
as in labeling experiments and as a source of conidia for UV irradia-
tion in experiments to be discussed later. Figure 2 gives the response 
of the pyr-4 ~ double mutant to a concentration series of four 
pyrimidines. The mutant utilizes thymidine, thymine and 5-hydroxy-
methyluracil equally well while uridine is used with less efficiency. 
It can be seen in Table 6 that all the pyr-4 uc-1 isolates found use 
uridine only about 50% as well as the parent pyr-4 strain. 
2-c14 thymidine and 2-c14 thymine labeling 
The results of administering pyrimidine ring labeled thymine and 
thymidine to the pyr-4 uc-1 double mutant are given in Table 8. With 
31 
Table 7.--Types of asci resulting from cross of pyr-4 uc-1 ~ 
(isolate 57) X 4A wild. 
Spore No. Spore No. 
Pair Asci Pair Asci 
1 pyr-4 uc-1 5 1 pyr-4 uc-1 2 
2 pyr-4 uc-1 2 + + 
3 + + 3 pyr-4 ~ 
4 + + 4 + + 
1 pyr-4 + . 6 1 pyr-4 uc-1 3 
2 pyr-4 uc-1 2 pyr-4 + 
3 + +Or uc-1 3 + + or uc-1 
4 + + or uc-1 4 + + or uc-1 
l pyr-4 + 2 
2 + + or uc-1 
3 pyr-4 uc-1 
4 + + or uc-1 
Parental ditype 7, Nonparental ditype O, Tetratype 11. 
No. 
Asci Mating Type 
pyr-4 segregating 1st division 14 
pyr-4 segregating 2nd division 4 
uc-1 segregation unclassified 2 
uc-1 segregating 1st division 5 
uc-1 segregating 2nd division 11 
Both segregating 1st division 5 
of these 5 
Parental combinations 5 
New combinations 0 
17 pyr-4 uc-1 
spore pairs 
Conclusion: Uc-1 segregates as a single gene; uc-1 and pyr-4 
are linked. 
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GROWTH RESPONSE OF py r -4 uc-1 DOUBLE MUTANT 
TO THYMIDINE 6-6, URI DINE ts .a. , THYMINE 0--0 
AND 5- HYDROXYMETHYLURACIL ®--e. EACH POINT 
IS THE AVERAGE DRY WEIGHT OF PADS FROM THREE 
FLASKS . TIME OF GROWTH WAS 6 DAYS. 
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Table 8.--Utilization and distribution of 2-c14 thymidine and 2-c14 
thymine label by pyr-4 uc-1 double mutant. 
Solution Counted 
Growth medium at start 
Growth medium at 6 days 
Alcohol extracts 
Alcohol-ether and ether extracts 
RNA extracts 
DNA extracts 
Per cent of label accounted 
for a~er 6 days growth 
Per cent of label at zero time 
found in RNA and DNA at 6 days 
Per cent of total nucleic acid 
counts due to DNA 
Mg RNA in pad 
Mg DNA in pad 
Per cent of total nucleic acid 
that is DNA 
CPM in Growth Medium and Pad Extracts 
2-cl4 thymidine 2-c14 thymine 
label label 
940,000 
246,ooo 
21,000 
500 
516,000 
27,000 
86°/o 
53 
l.08 
0.08 
1,230,000 
198,000 
11,000 
500 
696,000 
50,500 
73 
1.16 
0.11 
9.53 
Two flasks each containing 25 ml of growth medium + 1.0 µmole of 
2-c14 thymidine (specific activity approximately 0.75 µcurie/µmole) and 
a second two flasks containing 25 ml of growth medium + 1.0 µmole of 
2-cl4 thymine (specific activity approximately 1.0 µcurie/µmole) were 
inoculated with pyr-4 uc-1 conidia and grown six days at 25°c on a 
shaker. RNA and DNA determinations were made from the optical density 
of the two extracts at 260 and 268 mµ respectively. 
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both pyrimidines approximately 503 of the label initially present in 
the medium was recovered in the RNA fraction of the extracted mycelia. 
The specific activity of the DNA fraction (counts per minute in DNA/mg 
DNA) was not greater than the specific activity of the RNA fraction. 
Thus, the uc-l mutation does not affect the pyrimidine pathways in a 
way which would permit thymidine or thymine to become incorporated into 
DNA without passing through an RNA precursor pool. 
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PYR-4 UC-2 DOUBLE MUTANT 
Selection of mutant 
Several attempts were made to find mutants in which the pathway 
converting the pyrimidine ring of thymidine to an RNA precursor would 
be blocked at different steps. The first method used to select for 
such mutants was based on the finding that Pyr-4 conidia would produce 
larger colonies on sorbose plates containing very limiting uridine plus 
thymidine (0.18 µmole of uridine + 2.0 µmoles of thymidine) than on 
sorbose plates containing only the limiting uridine. Presumably mutants 
which could not utilize thymidine would produce small colonies on the 
uridine plus thymidine sorbose plates. 
The selection procedure consisted of treating a 1 X 106 pyr-4 
conidia/ml suspension with UV irradiation for 90 seconds (50 to 75% kill) 
and inoculating onto limiting uridine plus thymidine supplemented sor-
bose plates at a conidial concentration to produce five to twenty 
colonies per plate. At a time when the largest colonies to appear were 
almost ready to produce conidia the smallest colonies were transferred 
to agar tubes of complete medium. Each isolate was tested in two 
flasks of liquid medium, the first containing only a uridine supplement 
and the second uridine plus thymidine. Of the 2,100 colonies examined 
352 small colonies were isolated and tested further. Of these all but 
one were either slow growers or demonstrated a large thymidine for 
uridine sparing action in growth experiments. One isolate showed no 
sparing action of thymidine for uridine, but thymine and 5-hydroxy-
methyluracil did have a sparing action. The new mutation present in 
this isolate was given the designation uracil-2, abbreviated uc-2. 
Cross to wild type 
The pyr-4 uc-2 double mutant isolate was crossed to wild type 4~, 
asci were dissected and conidia from the germinated spore pairs were 
inoculated into liquid medium containing 1.0 µmole of uridine per flask 
and medium containing 1.0 µmole of uridine plus 1.0 µmole of thymidine 
per flask. As with the ~ mutant, the uc-2 mutant phenotype can only 
be observed when the pyr-4 mutation is present. The data in Table 9 
indicate that uc-2 and pyr-4 are not linked. However, the observation 
was made that all segregants known to be carrying the ~ mutation were 
~mating type when put into a sexual cross. Therefore, the uc-2 and 
mating type loci must be rather closely linked. 
Growth tests 
A pyr-4 uc-2 strain selected from those reisolated in the cross 
of pyr-4 uc-2 X 4~ was used in the growth response and c14 labeling ex-
periments. A uc-2 strain taken from the segregants of the above cross 
was also used in growth experiments and as a parent in later crosses in-
volving the uc-2 mutation. The dry pad weights reported in Table 10 
reveal that with both the pyr-4 and pyr-4 uc-2 mutants thymine and 
5-hydroxymethyluracil had a large sparing action for uridine while only 
the pyr-4 mutant gave a large sparing action with thymidine. Further-
more, the pyr-4 mutant can utilize deoxyuridine and deoxycytidine as 
pyrimidine sources while the pyr-4 ~mutant cannot. 
The action of the ~ mutation in preventing utilization of the 
three deoxypyrimidine nucleosides could be caused by an inactive deoxy-
pyrimidine nucleosidase enzyme. Although such enzymes have not been 
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Table 9.--Types of asci resulting from cross of pyr-4 uc-2 ~ X 4A wild. 
Spore 
Pair 
1 pyr-4 uc-2 
2 pyr-4 uc-2 
--3 + + 
4 + + 
1 pyr-4 + 
2 + + or uc-2 
3 + + or uc-2 
4 pyr-4 uc-2 --
1 + + or uc-2 
2 pyr-4 uc-2 
3 pyr-4 + 
4 + + or uc-2 
l + uc-2 
2 pyr-4 -+-
3 pyr-4 + . 
4 + uc-2 
No. Spore 
Asci Pair 
3 1 
2 
3 
4 
1 1 
2 
3 
4 
l l 
2 
3 
4 
l 
pyr-4 + 
pyr-4 uc-2 
+ +Or uc-2 
+ + or uc-2 
pyr-4 + 
+ + or uc-2 
pyr-4 uc-2 
+Or uc-2 + 
pyr-4 + 
pyr-4 + 
+ uc-2 
+ uc-2 
No. 
Asci 
1 
l 
3 
Parental ditype 3, Nonparental ditype 4, Tetratype 4. 
No. 
Asci Mating Type 
pyr-4 
pyr-4 
uc-2 
uc-2 
uc-2 
segregating 1st division 
segregating 2nd division 
segregation unclassified 
segregating 1st division 
segregating 2nd division 
7 
4 
3 
6 
2 
Both segregating lst division 6 
of these 6 
Parental combination 3 
New combinations 3 
12 ~ carrying 
spore pairs 
A 
0 
Conclusion: Uc-2 segregates as a single gene; uc-2 and pyr-4 are not 
linked. ~ and mating type lociaxe linked. 
a 
12 
Table 10.--Growth response of pyr-4 and pyr-4 uc-2 mutants to 
thymidine, deoxyuridine, deoxycytidine, thymine and 
5-hydroxymethyluracil. 
Pyrimidine Supplement Dry wt. ·{mg) of PadY 
µmoles/flask pyr-4 pyr-4 uc-2 
0.5 uridine 11 12 
0.5 uridine + 1.0 .thymidine 30 13 
0.5 uridine + 1.0 deoxyuridine 33 14 
0.5 uridine + 1.0 deoxycytidine 25 13 
0.5 uridine + 1.0 thymine 29 36 
0.5 uridine + 1.0 5-hydroxymethyluracil 35 40 
1.0 uridine 18 20 
1.0 uridine + .1.0 thymidine 38 20 
1.0 uridine + 1.0 deoxyuridine 43 21 
1.0 uridine + 1.0 deoxYcytidine 31 19 
1.0 uridine + 1.0 thymine 39 43 
Minimal 0 0 
1.0 thymidine 0 0 
1.0 deoxyuridine 20 3 
1.0 deoxycytidine 6 trace 
1.0 thymine 0 0 
1.0 5-hydroxymethyluracil 0 0 
bf Each figure is the average weight of two pads. Time of growth--
5 days. 
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worked with extensively they have been shown to act on a variety of 
deoxypyrimidine nucleosides while being unable to cleave deoxyribose 
purine and ribose pyrimidine nucleosides (39, 40). For these reasons 
growth experiments were undertaken to determine the growth inhibiting 
effect of the deoxypyrimidine nucleoside, 5-fluorodeoxyuridine (5-FUdR), 
on strains carrying the~ mutation (Table 11). 
In E. coli 5-FUdR acts as a growth inhibitor by specifically block-
ing the thymidylate synthetase enzyme (41). Attempts were made to use 
this specific inhibition to select for mutants of Neurospora which could 
phosphorylate thymidine. Observation of conidia on agar plates contain-
ing 5-FUdR showed that the conidia would germinate and grow very slowly 
for several days until finally overcoming the inhibiting effect, 
probably because of breakdown of the 5-FUdR by the mold. The fact that 
strains bearing the uc-2 mutation cannot overcome the inhibition of 
5-FUdR as rapidly as strains lacking it (Table 11) could be explained if 
one assumed that uc-2 carrying strains have much less deoxypyrimidine 
nucleosidase activity and as a result 5-FUdR is broken down less rapidly. 
The growth differences between pyr-4 and pyr-4 ~ mutants in the pres-
ence of 5-FUdR are not so large, probably because uridine is a competi-
tive inhibitor of 5-FUdR. 
Labeling experiment 
Data reported in Table 12 reveal that both mutants convert 65 to 
753 of the label originally present as 2-c14 thymine into RNA constitu-
ents. The pyr-4 mutant utilizes the label of 2-c14 thymidine similarly, 
but the pyr-4 uc-2 mutant transforms only 113 of this label into RNA 
40 
Table 11.--Effect of 5-fluorodeoxyuridine (5-FUdR) on growth of pyr-4, 
pyr-4 uc-2, uc-2 and 4~ strains. 
Pyrimidine Supplement Dry Wt. (mg) of PadY 
µmoles/flask pyr-4 pyr-4 uc-2 wild 
4A 
-
Minimal 0 0 94 
0.05 5-FUdR 51 
0.25 5-FUdR 16 
1.25 5-FUdR 3.6 
4.0 uridine 52 51 
4.0 uridine + 0.05 5-FUdR 57 42 
4.0 uridine + 0.25 5-FUdR 47 33 
4.0 uridine + 1.25 5-FUdR 28 15 
~Each figure is the average weight of two pads. Time of growth--
72 hours. 
uc-2 
116 
4.8 
1.6 
0.7 
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Table 12.--Utilization and distribution of 2-c14 thymidine and 2-c14 
thymine label by pyr-4 and pyr-4 uc-2 mutants. 
CPM in Growth Medium and Pad Extracts 
Solution Pyr-4 Mutant Pyr-4 Uc-2 Mutant 
Counted with 2-cl4 with 2-cl4 with 2-c14 with 2-cl4 
thymidine thymine thymidine thymine 
label label label label 
Growth medium at 
start 907,000 1,486,ooo 1,418,000 1,415,000 
Growth medium at 
90 hours 71,000 119,000 1,104,000 110,000 
Alcohol extract 10,000 39,000 17,000 28,000 
Alcohol-ether and 
ether extracts 500 1,000 1,500 500 
RNA extracts 660,000 890,000 135,000 966,000 
DNA extracts 51,000 81,000 14,000 87,000 
Per cent of label 
accounted for after 
90 hours growth 87% 76% 90°/o 84% 
Per cent of label at 
zero time found in 
RNA and DNA at 90 
hours 78% 65% 11°/o 74% 
Per cent of total 
nucleic acid counts 
due to DNA 7% 8% 9% 8% 
Mg RNA in pad 1.40 1.33 l.37 1.48 
Mg DNA in pad 0.138 0.143 0.132 0.130 
Per cent of total 
nucleic acid that 
is DNA 9.0°fo 9.7% 8.8°/o 8.1°/o 
Five flasks each containing 25 ml of growth medium + 1.0 µmole of 
uridine were prepared. To each of three flasks was added 1.0 µmole of 
2-cl4 thymidine (specific activity 1.5 µcuries/µmole) while the other 
two flasks each received 1.0 µmole of 2-cl4 thymine (specific activity 
2.0 µcuries/µmole). Pyr-4 uc-2 conidia were inoculated into two of the 
thymidine and one of the thymine supplemented flasks while pyr-4 
conidia provided the inoculum for the remaining two flasks. The mutants 
were grown on a shaker for 90 hours at 25°c. 
The two pyr-4 uc-2 pads from thymidine supplemented medium were 
only half the size of pads from the other flasks and were therefore 
combined for extraction. Each of the four pads extracted had a dry 
weight of about 35 to 40 mg~ 
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while over 75% remains in the growth medium, presumably as unused 
thymidine. If a weak thymidine phosphorylating system did exist in 
Neurospora, it might be expected that the DNA of the pyr-4 uc-2 
mutant grown in 2-c14 thymidine would have a higher specific activity 
than the RNA since the conversion of thymidine into an RNA precursor 
was largely blocked in this mutant. However, no evidence indicating a 
thymidine phosphorylating enzyme was found. The specific activities 
of the RNA and DNA extracts . (counts in RNA or DNA/mg RNA or DNA) of a 
pyr-4 uc-2 mutant administered 2-c14 thymidine were approximately the 
same. 
Other crosses involving uc-2 
A cross of uc-2 ~ X pyr-4 uc-1 .f!:. was made in order to obtain the 
pyr-4 uc-1 uc-2 triple mutant. The results of this cross and the type 
growth tests used to distinguish some of the possible mutant combina-
tions which could arise from the cross are shown in Table 13. The 
action of the uc-2 mutation in the prevention of all but slight utiliza-
tion of thymidine was also observed in the pyr-4 uc-l uc-2 triple 
mutants. In Table 13 and in future references to the triple mutant 
strain isolated from the uc-2 ~ X pyr-4 uc-1 .f!:. cross the suffix "I" will 
be added to the mutant designation to distinguish it from triple .mutants 
of similar phenotype which were isolated by other methods. 
The same uc-2 a mutant that was used in the above cross was mated 
to an adenine-6 (ad-6) mutant which is not linked to uc-2. The ad-6 
mutant can use deoxyadenosine as its sole purine source, and deoxy-
guanosine has a large sparing action in the presence of limiting 
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Table 13.--Types of asci resulting from cross of pyr-4 uc-1 ~ X ~ a. 
Spore 
Pair 
No. 
Asci 
Spore 
Pair 
No. 
Asci 
1 
2 
3 
4 
pyr-4 uc-1 + 
pyr-4 uc-1 + 
2 1 
2 
3 
4 
+ + uc-2 1 
pyr-4 uc-1 -+--
+ -+- uc-2 pyr-4 uc-1 + 
+ + + + uc-2 
1 
2 
3 
4 
pyr-4 uc-1 uc-2 
pyr-4 uc-1 uc-2 
3 1 
2 
3 
4 
pyr-4 uc-1 uc-2 1 
+ -+- +-Or uc-2 
+ + + pyr-4 uc-1 + 
+ + + + -+-- + or uc-2 
Conclusion: no recombination between pyr-4 and uc-1; uc-1 and uc-2 
segregate as unlinked single genes. 
Growth Tests to Distinguish Between 
Pyr-4, Pyr-4 Uc-1, Pyr-4 Uc-2, and Pyr-4 ~ Uc-2 Mutants 
Pyrimidine Dry Wt. (mg) of Pad]:7 
Supplement pyr-4 pyr-4 pyr-4 uc-1 pyr-4 uc-2 
µmo le s /flask uc-2 uc-2 I uc-1 
Minimal 0 0 0 0 169 
1.0 thymidine 0 0 0 20 
1.0 thymine 0 0 17 17 
1.0 uridine 16 19 13 13 
1.0 uridine + 
1. 0 thymidine 43 20 17 38 
!/Each figure is the average weight of three pads. Time of growth--
5 days. 
wild 
4A 
166 
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adenosine. Forty ad-6 carrying ascospores were taken from the cross 
and conidia from these isolates were inoculated into medium containing 
deoxyadenosine and medium containing adenosine plus deoxyguanosine. All 
40 isolates used the deoxypurines even though half of them should have 
been carrying the uc-2 mutation. Although uc-2 prevents use of deoxy-
pyrimidines it apparently does not affect deoxypurine utilization. 
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PYR-4 UC-1 UC-2 AND PYR-4 UC-1 UC-3 TRIPLE MUTANTS 
Selection of Mutants 
The possession of the pyr-4 ~ double mutant made possible a new 
selection procedure for finding mutants blocked in the pathway between 
thymidine and RNA. By employing a filtration enrichment procedure and 
growing UV irradiated pyr-4 ~ conidia in a medium containing thymidine 
the medium should become enriched in mutant conidia which cannot utilize 
thymidine. The summarized results of several filtration enrichment 
experiments are reported in the following paragraph. 
UV irradiation was applied to 90 X 106 pyr-4 uc-1 conidia to give 
a 30 to 5oa/o kill. The conidia were placed in medium containing 2.5 
µmoles of thymidine per 50 ml and incubated for 72 hours, with filtra-
tion when growth appeared. The remaining conidial suspension was 
inoculated onto sorbose plates containing 1.0 µmole of uridine per 25 ml 
of medium. Over a period of several days 921 colonies were removed from 
the sorbose plates and transferred to complete medium agar tubes. Of 
these, 101 were immediately discarded because of no or. very little growth 
on the complete medium. Those that remained were tested in liquid 
medium plus a thymidine supplement; 784 isolates grew in this medium and 
were discarded as being the parental double mutants. The remaining 36 
isolates were further tested in media containing uridine alone, thymi-
dine alone and uridine plus thymidine. Twenty isolates grew poorly with 
all pyrimidines and were discarded. Nine isolates would not grow on 
thymidine alone but did use thymidine to promote growth in the presence 
of limiting uridine. The possibility that some of these nine isolates 
46 
carry uc-1 suppressor mutations will be discussed later. Seven 
isolates (one of which was lost) met the requirements of the type 
mutant being searched for by growing well on uridine but not utilizing 
thymidine either alone or in the presence of uridine. Thus, each of 
these remaining six isolates must possess a third and new mutation. 
Growth tests 
The growth response of the six triple mutant isolates to eight 
different pyrimidines is given in Table 14. The growth tests divide 
the six triple mutants into two classes. One class, with two members, 
does not utilize thymidine, deoxyuridine and deoxycytidine while using 
the other pyrimidines. Since this is the same phenotype given by the 
pyr-4 uc-1 uc-2 I mutant previously recovered (Table 13) the new muta-
tion in these isolates was also designated uc-2 and the triple mutants 
were designated pyr-4 uc-1 uc~2 II and III respectively. The second 
class contained four isolates which could not benefit from thymidine, 
thymine and 5-hydroxymethyluracil as pyrimidine sources while they grew 
quite well on 5-formyluracil, uracil, uridine, deoxyuridine and deoxy-
cytidine. The new mutation present in these isolates was designated 
uracil-3 (uc-3). The four pyr-4 uc-1 uc-3 triple mutants are distin-
guished by the numerals I, II, III and IV. 
Heterocaryons 
In order to show possible functional differences among members of 
the two classes of triple mutants heterocaryons were made in liquid 
medium. Conidia from the mutants were inoculated into flasks contain-
ing 25 ml of medium plus various pyrimidine supplements and grown for 
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six days. As can be observed from the dry weights of the resulting 
pads (Table _15) the presumed heterocaryons formed between the pyr-4 
uc-1 ~ II and III mutants and among the four pyr-4 uc-1 uc-3 mutants 
gave no utilization of thymidine. However, heterocaryons between 
pyr-4 uc-1 uc-2 and pyr-4 uc-1 uc-3 triple mutants grew as would pyr-4 
uc-1 double mutants. Heterocaryons between pyr-4 ~~I and each 
of the two new uc-2 containing triple mutants gave no utilization of 
thymidine. 
Cross feeding experiments 
The possibility was investigated that some of the triple mutant 
isolates, when grown on a medium containing uridine plus excess 
thymidine, could convert thymidine to a pyrimidine that could be 
utilized by other triple mutant isolates. The results of the cross 
feeding experiments (Table 16) demonstrate that the mutants can again 
be divided into two classes. One class, the three pyr-4 ~ ~ 
mutants, excreted nothing into the medium that other uc-2 or uc-3 
carrying mutants could use as a pyrimidine source. The second class 
of four pyr-4 uc-1 uc-3 mutants converted thymidine to a compound or 
compounds available to all the pyr-4 uc-1 uc-2 mutants. 
The amount of growth produced by pyr-4 uc-1 ~ mutants growing 
in pyr-4 uc-1 uc-3 medium indicated that from one-half to almost all of 
the thymidine originally present had been converted to other pyrimidines 
by the pyr-4 uc-1 uc-3 mutants. No clue to the identity of the 
pyrimidine compound or compounds excreted by the uc-3 carrying triple 
mutants could be gained from the UV spectrum of the used medium since 
50 
Table 15.--Heterocaryon formation among six triple mutant isolates. 
Dry Wt. (mg) of Pad with the 
I no cul um~./ Following Pyrimidine Supplements (~moles[ flask~ l.O uridine 1.0 uridine + LO thymidine 
1.0 thymidine 
uc-2 II 9 9 0 
uc-2 III 12 12 0 
uc-2 II + uc-2 III 12 12 0 
uc-3 I 14 14 0 
uc-3 II 12 11 0 
uc-3 III 11 11 0 
uc-3 rv 10 10 0 
uc-3 I + uc-3 II 12 13 0 
uc-3 I + uc-3 III 13 14 0 
uc-3 I + uc-3 IV 13 13 0 
uc-3 II + uc-3 III 13 14 0 
uc-3 II + uc-3 IV 13 12 0 
uc-3 III + uc-3 IV 12 13 0 
uc-2 III + uc-3 I 15 57 20 
uc-2 III + uc-3 II 16 69 9 
!/Each of the mutants listed in this table also carry pyr-4 and uc-1 
mutations. 
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the presence of the pyr-4 mutation caused large amounts of orotic acid 
to be released into the medium as well. Although not conclusively 
proved, on the basis of growth response tests, heterocaryon formation 
and cross feeding experiments it was assumed that the uc-2 mutations 
of pyr-4 uc-1 uc-2 I, II and III were mutations of the same locus and 
that the uc-3 mutations of pyr-4 ~ uc-3 I, II, III and IV were 
mutations of the .same locus. 
Crosses 
One of the uc- 3 carrying triple mutant isolates, pyr-4 ~ uc- 3 I, 
was crossed to wild type. Types of asci resulting from this cross are 
reported in Table 17. Classification of spore pairs was made by deter-
mining growth in three pyrimidine supplemented media, 5-hydroxymethyl-
uracil alone, uridine alone and uridine plus 5-hydroxymethyluracil. As 
with the uc-1 and uc-2 mutations the uc-3 mutation cannot be classified 
by growth tests unless present with a pyr mutation. Furthermore, uc-1 
cannot be classified in the presence of uc-3 since the ability of uc-1 
to allow thymidine, thymine and 5-hydroxymethyluracil to be used as 
sole pyrimidine sources is nullified by the uc-3 mutation which does not 
allow the use of these compounds under any condition. However, since 
there was no recombination between pyr-4 and ~ in spore pairs that 
could be tested it was assumed that pyr-4 uc-3 spore pairs also carried 
uc-1. The asci gave no indication of linkage between uc-3 and pyr-4 
loci or uc-3 and mating type loci. 
A strain known to be carrying only the uc-3 mutation was selected 
from spore pairs of the previously discussed cross and was in turn 
53 
Table 17.--Types of asci resulting from cross of pyr-4 ~ uc-3 !:::_ X 
Spore 
Pair 
1 
2 
3 
4 
1 
2 
3 
4 
1 
2 
3 
4 
pyr-4 
pyr-4 
uc-3 
uc-3 
uc-3 
wild a. 
pyr-4 uc-1 uc-3 
pyr-4 uc-1 uc -3 
+ + + 
+ + + 
pyr-4 uc .:1 uc-3 
+ + + 
pyr-4 uc-1 uc-3 
+ + + 
pyr-4 uc-1 + 
pyr-4 uc-1 + 
+ + uc-3 
+ + uc-3 
No. 
Asci 
8 
1 
6 
segregating 1st division 
segregating 2nd division 
segregation unclassified 
segregating lst division 
segregating 2nd division 
Both segregating 1st division 
of these 14 
Parental combinations 
New combinations 
Spore 
Pair 
1 
2 
3 
4 
1 
2 
3 
4 
1 
2 
3 
4 
No. 
Asci 
14 
6 
5 
14 
1 
14 
8 
6 
+ + + or uc-3 
pyr-4 uc-1 
pyr-4 uc-1 uc-3 
+ + + or uc-3 
pyr-4 uc-1 uc-3 
+ + + or uc -3 
pyr-4 uc-1 
+ + + or uc-3 
pyr-4 uc-1 uc-3 
+ + + or uc-3 
+ + + or uc-3 
pyr-4 uc-1 + 
Mating 
A 
18 uc-3 carrying 
spore pairs 2 
No. 
Asci 
2 
2 
l 
Type 
a 
9 
Conclusion: Uc-3 segregates as a single gene. There is no evidence of 
linkage between uc-3 and pyr-4 or between uc-3 and mating 
type loci. 
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crossed to a pyr-1 mutant. The data in Table 18 show that pyr-1 and 
uc-3 loci are unlinked and that uc-3 gives the same phenotype in a 
pyr-1 background as in pyr-4. 
Identification of pyrimidine accumulated by uc-3 mutant 
The growth response and cross feeding experiments (Table 14 and 
16) indicated that the compound(s) likely to be accumulated by strains 
carrying the uc-3 mutation would be thymine and/or 5-hydroxymethyl-
uracil. In order to gain further information about the accumulated 
growth factor, wild type strains and strains known to be carrying 
the uc-3 mutation were grown for a period of five days in flasks con-
taining 25 ml of medium plus 20 µmoles of thymidine. The absorption 
spectra of wild type and uc-3 used media showed that both had the same 
wavelength of maximum absorption, 265 mµ. This was taken to indicate 
that the major pyrimidine(s) present in both media were thymine and/or 
thymidine. The used media of the uc-3 mutants still had 75 to 100% 
of the O.D. 265 that was present in the media at the start, while the 
used media of the wild type strains had only 25 to 50% of the original 
amount. 
In a procedure similar to the one used in the cross feeding ex-
periments (Table 16) uc-3 and wild type used media were used as the 
source of pyrimidines for growing pyr-4 uc-1 and pyr-4 uc-1 uc-2 (the 
uc-2 carrying mutant cannot utilize thymidine) mutants. By comparing 
the weights of pads produced by the two mutants on the used media to 
standard curves obtained by growing the two mutants on a concentration 
series of thymine, the amount of thymidine and of pyrimidines other 
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Table 18.--Types of asci resulting from cross of pyr-1 ~ X uc-3 fi· 
Spore 
Pair 
1 pyr-1 uc-3 
2 pyr-1 uc-3 
3 + + 
4 + + 
1 pyr-1 + 
2 pyr-1 + 
3 + uc-3 
4 + uc-3 
No. 
Asci 
6 
3 
Spore 
Pair 
1 
2 
3 
4 
1 
2 
3 
4 
pyr-1 uc-3 
pyr-1 + 
+ + or uc-3 
+ + or uc-3 
pyr-1 + 
pyr-1 uc-3 
+ + or uc-3 
+ + or uc-3 
No. 
Asci 
1 
1 
Nine random single ascospore isolates carrying the pyr-1 mutation were 
tested: five were pyr-1 and four were pyr-1 uc-3. 
No. 
Asci 
pyr-1 segregating 1st division 11 
pyr-1 segregating 2nd division 0 
uc-3 segregating 1st division 9 
uc-3 segregating 2nd division 2 
Both segregating 1st division 9 
of these 9 
Parental combinations 3 
New combinations 6 
Conclusion: Uc-3 segregates as a single gene. There is no evidence 
of linkage between uc-3 and pyr-1. 
Growth Tests Used to Distinguish Pyr-1 and Pyr-1 Uc-3 Mutants 
Dry Wt. (mg) of Pad!/ with the 
Inoculum Following Pyrimidine Supplement (µmoles/flask) 
minimal 1 .0 uridine 1.0 uridine + 1.0 uridine + 
2/ pyr-1- 'JI 
pyr-1 uc-3lt 
uc-3 
wild 
0 
0 
110 
123 
19 
18 
1.0 5-CH20H 1.0 uracil 
uracil 
35 
19 
34 
31 
!/Time of growth--5 days . 
~/Average weight of pads from growth tests of three pyr-1 spore pairs. 
J/Average weight of pads from growth tests of three pyr- 1 uc-3 
spore pairs. 
than thymidine in the used media were determined. These biological 
assays demonstrated that over 70% of the pyrimidine remaining in the 
used media of wild type strains was thymidine while in the used media 
of uc - 3 strains 70 to 100% of the growth factor was due to pyrimidines 
other than thymidine . The assays further showed that both wild type 
and uc-3 used media had about the same level of thymidine, but only 
the uc-3 medium had an appreciable amount of another pyrimidine . Both 
strains were capable of degrading a large amount of thymidine, but 
only uc-3 accumulated one of the early products of degradation. 
The used medium of a uc-3 mutant (which had been grown in a 
medium containing thymidine) was applied to a Dowex-50 column and 
eluted with 1.5 N HCl as described · in the materials and methods sec-
tion . Two peaks with UV absorption at 265 mµ were eluted from the 
column . The component of the smaller peak had an absorption maximum 
at 266 mµ. This component and added thymidine were simultaneously 
eluted from the column . The component of the major peak had an ab-
sorption maximum at 265 mµ. This component and added thymine could 
not be separated on the Dowex-50 column . The fractions comprising the 
major peak were pooled, dried, redissolved in a small amount of water 
and compared with three other pyrimidines by one dimensional paper 
chromatography. The location of the compounds, a~er development of 
the chromatograms, was determined by the appearance of absorbing spots 
on the Whatman No. l paper under a short wavelength UV lamp. The 
results of Table 19 ver ify that the major component accumulated in uc-3 
used medium is thymine . 
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Table 19.--Approximate RF values of pyrimidines. 
Pyrimidine 
5-CH20H uracil 
Thymidine 
Thymine 
Accumulated by 
uc-3 mutant 
.77 
.81 
.70 
.69 
ethyl acetate-
formic acid-H20 
(70:20:10) 
-37 
.59 
.67 
.67 
t·butanol-methyl 
ethyl ketone-H20 
NH40H (40:30:20:10) 
• 34 
.63 
.59 
.59 
58 
No 5-hydroxymethyluracil or pyrimidine other than thymidine or 
thymine was detected in the eluate from the ion exchange column. Data 
in Table 20 show that the growth factor in uc-3 used medium which 
accounts for essentially all the pyrimidine in the used medium avail-
able to the pyr-4 uc-1 ~mutant is thymine. Thus, the uc-3 
mutation, shown by growth experiments to block the thymine methyl 
oxidative pathwa~ between 5-hydroxymethyluracil and 5-formyluracil, 
causes accumulation of thymine, but not 5-hydroxymethyluracil. A 
possible explanation of this could be that the steps from thymine to 
5-formyluracil are carried out by one enzyme. 
Suppressor of ~ mutation 
During selection of the seven pyr-4 uc-1 uc-2 and pyr-4 uc-1 uc-3 
triple mutants, nine isolates were found which behaved in growth tests 
as pyr-4 mutants. These nine isolates would not grow in medium in 
which thymidine was the only pyrimidine source, but would utilize 
thymidine when uridine was present. One of these isolates was crossed 
to wild type, 10 asci were dissected and the germinated spore pairs 
were classified as to whether or not they carried the pyr-4 mutation. 
Conidia arising from the growth of the two pyr-4 carrying spore pairs 
of each ascus were inoculated into flasks containing 25 ml of medium 
plus 1.0 µmole of thymidine. The growth results from the 10 asci are 
as follows: 4 asci--neither pyr-4 segregant produced growth, 5 asci--
one pyr-4 carrying segregant produced growth (pyr-4 uc-1 phenotype) 
the other did not, 1 ascus--both pyr-4 carrying segregants produced 
growth. This reveals that the parent isolate was still carrying the 
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60 
uc - 1 mutation and must also have had a third mutation, a suppressor of 
uc-1 (uc-1-su). Since the growth tests do not distinguish among the 
three genotypes pyr-4, pyr-4 uc -1 uc-1-su and pyr-4 uc-1-su and be-
cause a limited number of asci were dissected no definite statement 
can be made about the possible linkage of uc-1 and uc -1-su. 
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PYR-1 uc-4 AND PYR-1 UC-5 DOUBLE MUTANTS 
Selection of mutants 
A filtration enrichment procedure was used to select for mutants 
which could not utilize uracil, but still could use uridine as a 
pyrimidine source. UV irradiation was applied to 20 X 106 pyr-1 
conidia for 35 seconds to give a 33% kill . The conidia were placed in 
medium containing 0 .75 µmole of uracil per 25 ml (2 X 105 conidia/ml) 
and grown for 62 hours using procedures previously described for fil-
tration enrichment. The conidial suspension remaining a~er 62 hours 
was inoculated onto sorbose plates containing 0 . 5 µmole of uridine per 
25 ml of medium. From the third to the seventh day following inocula-
tion of the sorbose plates 327 colonies were removed and transferred to 
agar tubes of complete medium. Sixty of these isolates were discarded 
because of poor growth on the complete agar medium . The remainder were 
tested in liquid medium supplemented with uracil and medium supplemented 
with uridine. All but four isolates were discarded because they be-
haved as pyr-1 mutants or because they grew poorly on both media . The 
four isolates kept would not grow in the uracil supplemented medium, 
but did respond to uridine . 
The four presumed double mutants were then tested in media con-
taining limiting uridine further supplemented with one of the follow-
ing pyrimidines : thymidine, thymine, 5-hydroxymethyluracil or uracil . 
One of the isolates received no sparing action from any of the four 
pyrimidine supplements and the new mutation carried by this isolate was 
designated uracil-4 (uc- 4). The other three mutants could not benefit 
62 
from thymine, 5-hydroxymethyluracil and uracil, but thymidine did give 
a sparing action. The new mutation carried by this class of mutants 
was designated uracil-5 (uc-5). 
Crosses 
The pyr-1 uc-4 and one of the pyr-1 uc-5 isolates were crossed to 
wild type 4~, asci were dissected and conidia from growth of the dis-
sected spore pairs were tested in several pyrimidine supplemented 
media. The results of the crosses and the type of growth tests used 
in classification of the spore pairs are given in Table 21 for the 
pyr-1 uc-4 mutant and in Table 22 for the pyr-1 uc- 5 mutant. As with 
the other ~ mutations the presence of uc-4 and uc-5 can be determined 
by growth tests only when they are with a pyr mutation. Uc-4 was found 
to be linked to the mating type locus while uc-5 was found linked to 
the pyr-1 locus. 
The initial pyr-1 uc-4 isolate gave only about one-third the 
growth at any given uridine concentration as did the pyr-1 parent. All 
pyr-1 uc-4 segregants resulting from the backcross of the double mutant 
to wild type also behaved in this manner. Apparently, the reduced 
efficiency of uridine utilization and resulting reduced growth are 
caused by the uc-4 mutation and not a second independent mutation. 
Growth tests 
Pyr-1 uc-4 and pyr-1 uc-5 double mutants were reisolated from the 
backcross to wild type. The growth response of these double mutants and 
the pyr-1 parent to ten different pyrimidines is · given in Table 23. 
Table 21.--Types of asci resulting f'rom cross of pyr-1 uc-4 ~ X 4A 
wild. 
Spore 
Pair 
No. Spore No. 
Asci Pair Asci 
1 
2 
3 
4 
pyr-1 uc-4 4 
pyr-1 uc-4 
+ + 
+ + 
1 pyr-1 + 
2 pyr-1 + 
3 + uc-4 
4 + uc-4 
Six random single spore isolates carrying the pyr-1 mutation were 
tested: three were pyr-1 and three were pyr-1 uc-4. 
4 
No. 
Asci Mating Type 
pyr-1 segregating 1st division 
pyr-1 segregating 2nd division 
uc-4 segregating 1st division 
uc-4 segregating 2nd division 
Both segregating 1st division 
of these 
Parental combinations 
New combinations 
8 
0 
8 
0 
8 
4 
4 
A 
16 uc-4 carrying 
spore pairs 1 
Conclusion: Uc-4 segregates as a single gene; uc-4 and pyr-1 are not 
linked. Uc-4 and mating type loci---are linked. 
Growth Tests Used to Distinguish Pyr-1 and Pyr-1 Uc-4 Mutants 
a 
15 
Pyrimidine Supplement 
µmoles/flask 
,Dry Wt. (mg) of Pad1:/ 
pyr-i?J pyr-1 uc-43/ 
1.0 uracil 
LO uridine 
2.0 uridine 
1 .0 uridine + 1.0 thymidine 
1.0 uridine + 1.0 thymine 
1.0 uridine + 1 .0 uracil 
11.5 
14.4 
23.7 
28.8 
26.2 
21.8 
o.o 
5.9 
l0.5 
6.3 
5.4 
5.6 
.f7Time of growth--5 days. 
'?:.!Average of pads from growth tests of four pyr-1 spore pairs. 
J/Average of pads from growth tests of eleven pyr-1 uc-4 spore pairs. 
'• 
64 
Table 22.--Types of asci resulting from cross of pyr-1 uc-5 ~ X 4~ 
wild. 
Spore 
Pair 
1 
2 
3 
4 
1 
2 
3 
4 
pyr-1 uc-5 
pyr-1 uc-5 
+ + 
+ + 
+ + 
pyr-1 uc-5 
pyr-1 uc-5 
+ + 
No. 
Asci 
7 
1 
Spore 
Pair 
1 pyr-1 + 
2 pyr-1 + 
3 + uc-5 
4 + uc-5 
1 pyr-1 + 
2 pyr-1 uc-5 
3 + + or uc-5 
4 + + or uc-5 
No. 
Asci 
0 
1 
Seventeen random single spore isolates carrying the pyr-1 mutation were 
tested: two were pyr-1 and fifteen were pyr-1 uc-5. 
pyr-1 segregating 1st division 
pyr-1 segregating 2nd division 
uc-5 segregating 1st division 
uc-5 segregating 2nd division 
Both segregating 1st division 
of these 
Parental combinations 
New combinations 
No. 
Asci 
8 
1 
7 
2 
7 
7 
0 
10 uc-5 carrying 
spore pairs 
Mating Type 
A a 
6 4 
Conclusion: Uc-5 segregates as a single gene; Uc-5 and pyr-1 are linked. 
Growth Tests Used to Distinguish Pyr-1 and Pyr-1 Uc-5 Mutants 
Pyrimidine Supplement 
µmoles/flask 
1.0 uracil 
1.0 uridine 
2.0 uridine 
1.0 uridine + 1.0 thyrnidine 
LO uridine + 1.0 thymine 
1.0 uridine + 1.0 uracil 
pyr-1 
20.l 
18.9 
29.5 
30.9 
30.6 
29.8 
Dry Wt. (mg) of Pad~/ 
pyr-1 uc-5E./ 
0.5 
15.6 
26.0 
27 .9 
16.3 
17 .6 
l}Time of growth--5 days. 
g/Average weight of pads from growth tests of ten pyr-1 uc-5 spore pairs. 
Table 23.--Growth response to several pyrimidines of parent pyr-1 
mutant and pyr-1 uc-4 and pyr-1 uc-5 double mutants. 
Dry Wt. 1 (mg) of Pad-
Pyrimidine Supplement pyr-1 pyr-1 pyr-1 
µmoles/flask uc-4 uc-5 
3.0 uridine 14.9 47 43 
2.0 uridine 10.7 36 33 
LO uridine 5.7 21 18 
LO uridine + 1.0 thymidine 6.4 38 32 
1.0 uridine + 1. 0 thymine 6.1 22 31 
1.0 uridine + 1.0 5-CH20H uracil 5 .7 22 32 
1.0 uridine + 1.0 5-formyluracil 5.8 21 30 
1.0 uridine + 1.0 uracil 5.9 25 31 
LO uridine + 1.0 deoxyuridine 8.1 41 34 
1.0 uridine + 1.0 deoxycytidine 7.8 30 27 
1.0 uridine + 1.0 cytidine l0.9 38 30 
1.0 uridine + 1.0 cytosine 5.6 21 20 
1.0 cytidine 4.7 22 18 
1.0 deoxyuridine o.o 2 14 
1.0 deoxycytidine o.o 4 1 
1. 0 cytosine o.o 0 0 
1.0 thymidine o.o 5 0 
1.0 uracil o.o 1 18 
2.0 uridine + 1.0 thymidine 11.6 
2.0 uridine + 1.0 thymine 10.2 
2.0 uridine + 1.0 uracil l0.9 
3:/Each figure is the average of two pads. Time of growth--5 days. 
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The action of the uc-4 mutation seems to be that of blocking the 
pathway by which the pyrimidine ring of thymidine can be used for in-
corporation into RNA since thymidine, thymine, 5-hydroxymethyluracil, 
5-formyluracil and uracil are not utilized by the pyr-1 uc-4 mutant. 
The action of the uc-5 mutation is . far from clear since it allows 
thymidine, the first compound in the pathway, to be used but does not 
allow utilization of the pyrimidines following thymidine in the path-
way. The pyr-1 uc-5 mutant can utilize deoxyuridine and deoxycytidine 
in addition to thymidine. The uc - 5 mutation could be looked upon as 
affecting active transport, that is allowing pyrimidine nucleosides 
to be carried into the cell, but not the pyrimidine bases. Whether 
Neurospora is completely dependent on active transport mechanisms to 
get pyrimidines inside the cell and if it is, whether it has separate 
systems for pyrimidine bases and nucleosides is not known. The pos-
sibility that the uc-5 mutation affects the regulation of the oxida-
tive pathway cannot be ruled out. However, a pyr-1 uc-5 strain grown 
in medium supplemented with 1.0 µmole amounts of uridine and thymidine 
and medium containing 1.0 µmole amounts of uridine, thymidine and 
thymine gave the same amount of growth in both media. 
Accumulation products 
Pyr-1, pyr-1 uc-4 and pyr-1 uc-5 mutants were grown in medium con-
taining 6.0 µmoles of uridine per flask. At the end of three days the 
pyr-1 used medium contained no pyrimidine, the pyr-1 uc-5 used medium 
contained 2.0 µmoles of uracil and the pyr-1 uc-4 used medium had 3.0 
µmoles of uracil. At the end of five days growth the pyr-1 uc-5 used 
medium had almost no uracil lef't while the pyr-1 uc-4 used medium still 
contained almost 3.0 µmoles of uracil. The pyrimidine components of 
the used medium were eluted from a Dowex-50 column with water . .Amounts 
of pyrimidine in the eluant were determined by the o.n.260 • 
As reported in Table 24, the ability of wild type 4~ and of uc - 4 
strains to utilize uridine and uracil was investigated. Wild type 
rapidly takes up· uracil and uridine, and excretes essentially no 
pyrimidine into the medium. The uc-4 strain rapidly takes up uridine, 
but releases almost half of it as uracil which it cannot use. This 
seems to explain why the pyr-1 uc-4 mutant gives less growth from 
uridine than the pyr-1 mutant. 
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Table 24.--Accumulation of uracil by uc-4 mutant grown with excess 
uridine in medium. 
Hours Dry wt. 1::1:Moles Left in Medium of 
Inoculum Growth (mg) of Uri dine Uracil 
Pad 
4A 0 0 9.2 o.o 
4A 40 6 7.9 o.o 
4A 48 17 4.1 0.5 
4A 58 46 o.o o.o 
4A 70 84 o.o o.o 
Uc-4 0 0 9.2 o.o 
Uc-4 40 10 6.5 1.2 
Uc-4 48 29 o.o 5.5 
Uc-4 58 49 o.o 5.1 
Uc-4 70 101 o.o 4.5 
Wild type 4A and uc-4 strains were inoculated into two series of 
flasks, each flask containing 25 ml of medium + approximately 10 µmoles 
of uridine. A flask was incubated for the period of time listed in the 
above table after which the mycelial pad was removed and a one to two 
ml aliquot of the used medium was applied to a 1.3 X 50 cm Dowex-50 
column. The pyrimidine components were eluted from the colwnn with H20 
and two ml volume fractions were collected. No major 240-290 mµ ab-
sorbing materials other than uracil and uridine were eluted from the 
column. Uridine and uracil were identified by their effluent volumes 
and their respective UV absorption maximums of 261 and 258 mµ. 
Uc-4 and wild type strains were used in identical experiments 
except instead of uridine the supplement was 10 µmoles of uracil per 
flask. The wild type strain had removed all the uracil from the 
medium by 58 hours of growth (49 mg pad). While at 58 hours of growth 
the uc-4 mutant used medium still contained almost 10 µmoles of uracil 
(57 mg pad). 
PYR-1 UD-1 AND PYR-1 UD-2 DOUBLE MUTANTS 
Introduction 
In the previous section was discussed the isolation of a group 
of mutants which could utilize uridine but not uracil. One of these 
mutants, uc-4, was presumed to be unable to incorporate uracil into 
nucleic acid. Since the uc-4 mutant could utilize uridine the assump-
tion was made that uridine is phosphorylated directly and is not con-
verted to uracil before incorporation into nucleic acid. Radioactive 
labeled nucleoside experiments with many organisms (13) including 
Neurospora (17, 42) have shown that all ribonucleosides are probably 
directly phosphorylated. The question that remained unanswered was 
whether uracil could be directly converted to uridine monophosphate 
such as through a reaction with 5-phosphoribosylpyrophosphate, or 
whether it was converted to uridine first. Proof for a pathway by 
which uracil could become incorporated into nucleic acid without 
passing through a uridine intermediate might be the finding of mutants 
which could utilize uracil but not uridine. 
Selection of mutants 
A filtration enrichment procedure was used to select for mutants 
which could not utilize uridine but still could use uracil as a pyrimi-
dine source . A pyr-1 conidial suspension was given UV irradiation for 
40 seconds (55% kill) and inoculated into two flasks each containing 
33 ml Fries medium (2 X 105 conidia/ml of medium) supplemented with 
1.0 µmole of uridine. The conidial suspension remaining after 44 hours 
of growth (using previously described filtration enrichment procedures) 
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was spread onto sorbose plates containing 0.5 µmole of uracil per 25 
ml of medium. Of the 643 colonies removed from the sorbose plates and 
transferred to agar tubes of complete medium all but 45, which were 
discarded as slow growers, were tested further. Inoculum from each 
isolated colony was transferred to two flasks; one containing 25 ml 
of Fries medium plus 1 . 0 µmole of uridine and the other 25 ml of 
Westergaard-Mitchell medium plus 1.0 µmole of uracil. The uridine 
supplement was placed in Fries medium to protect against the possi-
bility that mutants which could not utilize uridine might be discarded 
because they possessed an adaptive system to convert uridine to uracil. 
Uracil is used inefficiently by pyr mutants in Fries medium. 
Four isolates grew poorly or not at all on the uridine supple-
mented medium while growing normally on the medium containing uracil. 
These four presumed double mutants were further tested in Fries and 
Westergaard-Mitchell media supplemented with one of the following pyrim-
idines: uridine, cytidine, deoxyuridine and uracil. One isolate be-
haved like the pyr-1 parent on the uracil supplemented media, but 
could not utilize the three nucleosides on either medium. The new 
mutation present in this isolate was designated uridine-1, abbreviated 
ud-1. An unexpected finding was that the other three isolates utilized 
the four pyrimidine supplements just as did the pyr-1 parent in 
Westergaard-Mitchell medium, but could not use any of them in Fries 
medium. The new mutation present in these three isolates was desig-
nated uridine-2 (ud-2). 
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Crosses 
The pyr-1 ud-1 and one of the pyr-1 ~ isolates were crossed to 
wild type 4~ asci were dissected and conidia f'rom the growth of the 
dissected spore pairs were inoculated into flasks of Fries medium 
supplemented with 1.0 µmole of uridine. If little or no growth occurred 
in this medium, indicating the presence of the pyr-1 ud double mutant, 
the segregant was always further checked in Westergaard-Mitchell medium 
supplemented with uracil to insure that it co~ld utilize uracil. Segre-
gants known to be carrying only the ud-1 or ud-2 mutation grew in 
minimal medium like wild type. 
The results of the crosses are given in Table 25 for the pyr-1 
ud-1 mutant and in Table 26 for the pyr-l ud-2 mutant. There was no 
proof for the linkage of the ud mutations either to the pyr-1 or the 
mating type locus. Of the asci dissected from the backcross of the 
pyr-1 ud-2 mutant to 4~ only three parental ditypes were recovered 
compared to eight non-parental ditypes. The deficiency of parental 
ditypes could be due to chance (as small numbers of asci were involved), 
to poor germination of spore pairs carrying both the pyr-1 and ud-2 
mutations (at least one of the four spore pairs failed to germinate in 
about one-third of the asci dissected) or to more than one gene con-
tributing to the phenotype. However, all the pyr-1 ud-2 segregants 
were indistinguishable by growth tests from the parent double mutant. 
The pyr-1 segregants were no different than the original pyr-1 mutant. 
If two genes are involved in the ~ phenotype, they have no visible 
effect unless present together. 
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Table 25.--Types of asci resulting from cross of pyr-1 ud-1 ~ X 4~ wild. 
Spore No. 
Pair Asci 
1 pyr-1 ud-1 8 
2 pyr-1 ud-1 
3 + + 
4 + + 
1 pyr-1 ud-1 l 
2 pyr-1 + 
3 + + or ud-1 
4 + + or ud-1 
1 pyr-1 ud-1 2 
2 + +or ud-1 
3 pyr-1 + 
4 + + or ud-1 
pyr-1 segregating 1st division 
pyr-1 segregating 2nd division 
No. 
Asci 
17 
3 
ud-1 segregation unclassified 3 
ud-1 segregating 1st division 15 
ud-1 .segregating 2nd division 2 
Both segregating 1st division 15 
of these 15 
Parental combinations 8 
New combinations 7 
Spore No. 
Pair Asci 
1 pyr-1 ud-1 1 
2 + +or ud-1 
3 + + or ud-1 
4 pyr-1 + 
l pyr-1 + l 
2 pyr-1 ud-1 
--3 + + or ud-1 
4 + + or ud-1 
1 pyr-1 + 7 
2 pyr-1 + 
3 + ud-1 
4 + ud- 1 
Mating Type 
20 ud-1 carrying 
spore pairs 
A 
9 
a 
11 
Conclusion: Ud-1 segregates as a single gene. There is no indication 
of linkage between ud-1 and pyr-1 or ud-1 and mating type 
loci. -
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Table 26.--Types of asci resulting from cross of pyr-1 ud-2 .§:_ X 4A wild. 
Spore No. Spore No. 
Pair Asci Pair Asci 
1 pyr-1 ud-2 3 1 pyr-1 + 8 
2 pyr-1 ud-2 2 pyr-1 + 
--3 + + 3 + ud-2 
4 + + 4 + ud-2 
1 pyr-1 ud-2 6 
2 pyr-1 + . 
3 + + or ud-2 
4 + + or ud-2 
No. 
Asci Mating Type 
A a 
20 ud-2 carrying 
pyr-1 segregating 1st division 
pyr-1 segregating 2nd division 
ud-2 segregating 1st division 
ud-2 segregating 2nd division 
Both segregating 1st division 
17 
0 
11 
6 
11 
spore pairs 8 12 
of these 11 
Parental combinations 
New combinations 
3 
8 
Conclusion: There is no indication of linkage between ud-2 and pyr-1 
or ud-2 and mating type loci. 
Growth Tests Used to Distinguish Pyr-1 and Pyr-1 Ud-2 Mutants 
Dry Wt. (mg) of Pad~/ Grown in 25 ml Fries Medium + 1.0 µmole Uridine 
pyr-1 ~ pyr-1 ud-2 wild 
1.7 24 122 146 
~/Time of growth--5 days. Figures are average weight of pads from 
testing 10 spore pairs each of pyr-1 ud-2, pyr-1, ud-2 and wild type 
genotypes. 
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Growth tests 
Pyr-1 ud-1 and pyr-1 ud-2 double mutants which were reisolatcd 
from the backcross of the original mutant isolates to wild type were 
used in growth response tests. The growth response of the pyr-1 ud-1 
mutant to ten different EYTimidines is given in Table 27. The results 
of these growth tests are curious for they show that the ud-1 mutation 
allows the utilization of thymine, 5-hydroxymethyluracil, 5-formyl-
uracil and uracil, but not of uridine, cytidine, deoxyuridine, 
deoxycytidine and thymidine. The previously discussed uc-4 mutation 
(Table 23) gave exactly opposite results; permitted utilization of the 
nucleosides but not of the f'ree bases. The action of the two mutations, 
uc-4 and ud-1, suggests that they are affecting specific pyrimidine 
transport systems. 
The growth response of the pyr-1 ud-2 mutant to several pyrimidines 
in both Fries and Westergaard-Mitchell medium is given in Table 28. An 
explanation of why the pyr-1 ~ mutant is a more efficient user of 
pyrimidines on one medium (Westergaard-Mitchell) than the pyr-1 parent 
while utilizing all pyrimidines very inefficiently on another medium 
(Fries) is difficult. Davis and Zimmerman (43) reported a mutant of 
Neurospora, UM-300, which in combination with arginine mutants pre-
vented utilization of arginine from the medium. Other double mutant 
combinations involving UM-300 showed that the uptake of lysine, other 
amino acids and uridine were affected. The difficulties of assimilation 
of UM-300 strains were conditional upon the presence of ammonium in the 
medium. Although it would have been of interest the ud-2 mutation was 
not transferred into amino acid mutant strains to determine if this 
mutation prevented the utilization of amino acids. 
- ~ · 
75 
Table Z{. --Growth response to several pyrimidines of parent pyr-1 
mutant and pyr-1 ud-1 double mutant. 
Pyrimidine Supplement Dry wt. ~mgl of PadY 
µmoles/flask pyr-1 pyr-1 ud-1 
3.0 uracil 40 37 
2.0 uracil 30 28 
1.0 uracil 18 18 
1.0 uracil + 1.0 thymidine 29 19 
1.0 uracil + 1.0 thymine 29 31 
1.0 uracil + 1.0 5-CH20H uracil 31 25 
1.0 uracil + 1.0 5-formyluracil 34 zr 
1.0 uracil + 1. 0 uridine 31 20 
1.0 uracil + 1.0 cytidine 29 19 
1.0 uracil + 1.0 deoxyuridine 31 19 
1.0 uracil + 1.0 deoxycytidine 28 19 
1.0 uracil + 1.0 cytosine 19 21 
1.0 uridine 18 0 
1.0 cytidine 19 0 
1.0 deoxyuridine 12 4 
1.0 deoxycytidine 0 0 
1.0 cytosine 0 0 
1.0 thymidine 0 0 
LO thymine 0 0 
~Each figure is the average weight of two pads . Time of growth--5 days. 
Westergaard-Mitchell growth medium. 
Table 28.--Growth response of parent pyr-1 mutant and pyr-1 ud-2 
double mutant to several pyrimidines in two different 
growth media. 
Pyrimidine Dry Wt. (mg) of Pad~/ 
Supplement Westergaard-Mitchell Medium Fries Medium 
µmoles/flask pyr-1 pyr-1 ud-2 pyr-1 pyr-1 ~ 
1.0 uridine 17 21 19 
1.0 uridine + 
1.0 thymidine 25 38 26 
1.0 uridine + 
1.0 thymine 28 40 24 
1.0 cytidine 21 19 18 
1.0 deoxyuridine 11 23 6 
1.0 deoxycytidine 2 3 6 
1.0 uracil 19 25 5 
1.0 uracil + 
1.0 thymidine 25 41 7 
1.0 thymidine 0 4 0 
1.0 thymine 0 8 0 
LO cytosine 0 0 0 
!/Each figure is the average weight of two pads. Time of growth--5 
days. 
2 
2 
3 
0 
1 
0 
0 
1 
0 
0 
0 
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DISCUSSION 
Neurospora crassa does not possess a thyrnidine phosphorylating 
enzyme and specific labeling of the fungus DNA with thymidine is 
impossible. However, Neurospora does have a metabolic pathway for 
the conversion of the pyrimidine ring of thymidine into an RNA pre-
cursor. As a means toward clearly defining this pathway mutant isola-
tion procedures were devised and mutants were found in which specific 
biosynthetic reactions of the thymidine to RNA precursor conversion 
were blocked. In addition, these isolation procedures yielded muta-
tions which prevent the uptake of pyrimidines from the growth medium 
and mutations which affect the regulation of one or more steps in the 
thymidine to RNA precursor pathway. A more detailed discussion of 
each of these conclusions and findings follows. 
Inability of Neurospora to phosphorylate deoxyribose nucleosides 
Experiments in which 2-c14 thymidine and thymine were administered 
to Neurospora showed that the majority of the label was incorporated 
into the RNA of the fungus and supported the hypothesis of Fink (9) 
that Neurospora lacks a thymidine phosphorylating enzyme. An alter-
native hypothesis was suggested by the report (44) that in Escherichia 
~radioactive labeled thymidine is at first readily incorporated 
into DNA, but after a short period of time the level of incorporation 
drops rapidly. This phenomenon is caused by an inducible nucleosidase 
enzyme which converts thymidine to thymine, the latter compound being 
very inefficiently incorporated into DNA by ~· coli. Therefore, 
Neurospora might have a thymidine phosphorylating system of low 
activity which would not be detected because of the rapid conversion 
of its substrate, thymidine, to compounds which are unavailable for 
specific incorporation into DNA. 
An answer to the question of whether Neurospora does or does not 
have a thymidine phosphorylating enzyme was obtained by administering 
labeled thymidine . to a mutant (uc-2) in which the thymidine to thymine 
conversion step is almost completely blocked. The majority of added 
thymidine remained in the medium ·(80%) while ninety per cent of the 
small amount of label which did become incorporated into the nucleic 
acid was in the RNA fraction. These results substantiate the hypothesis 
that Neurospora lacks a thymidine phosphorylating enzyme and gives 
evidence that the conversion of thymidine to thymine is the only enzy-
matic reaction thymidine can undergo in this organism. 
A conversation with Professor Sterling Emerson provided the infor-
mation that other researchers had attempted, unsuccessfully, to label 
specifically the DNA of various fungi species using radioactive 
thymidine. The presence of a pathway to convert thymidine to an RNA 
precursor and/or the lack of ability to phosphorylate thymidine are 
quite likely to be common among the fungi. An inability to phosphoryl-
ate thymidine has been reported (45) for the Psittacosis virus while 
evidence for the presence of a thymidine to RNA precursor pathway 
exists in Acetabularia (2), Spirogyra (3, 4), Paramecium (5) and rat 
liver (11) (see introduction section). The pathway for the conversion 
of thymidine into an RNA component is undoubtedly present or capable 
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of being induced in a large number of other organisms. The possibility 
of the presence of this pathway should be considered in any experiments 
utilizing thymidine for the specific labeling of DNA. 
The response of Neurospora to deoxynucleosides other than 
thymidine was also investigated. Radioactive labeling experiments and/ 
or growth response tests using deoxyuridine, deoxycytidine, deoxy-
adenosine and deoxyguanosine showed that these nucleosides are 
rapidly converted to their respective pyrimidine and purine bases which 
are in turn efficiently utilized as RNA precursors. Although not con-
clusive this evidence suggests that Neurospora may lack phosphorylating 
enzymes for all deoxyribose nucleosides. Therefore, a Neurospora 
strain would require two mutations to permit specific DNA labeling using 
a radioactive deoxyribose nucleoside. One mutation would be required 
to prevent the cleavage of the nucleoside to the free base and the 
second to alter the specificity of a ribose nucleoside phosphorylat-
ing enzyme in such a way that the enzyme could phosphorylate a deoxy-
ribose nucleoside. Mutants of the first type were found, but selection 
procedures for mutants which could phosphorylate thymidine were 
unsuccessful. 
Mutations blocking the thymidine to RNA precursor pathway 
One approach for determining the actual reactions involved in the 
pathway which converts the pyrimidine ring of thymidine to an RNA 
component was the isolation of mutants in which the pathway was 
blocked. Evidence gathered from genetic work, nutritional studies and 
accumulation studies with these mutants, uc-2, uc-3 and uc-4, is 
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consistent with the conclusion that each of these mutants acts by 
blocking a biosynthetic reaction in the thymidine to RNA precursor 
pathway. This pathway, based on the action of the uc-2, uc-3 and 
uc-4 mutations, is outlined in figure 3. 
In addition to blocking the thymidine to thymine conversion step 
the uc-2 mutation prevents the utilization of deoxyuridine and deoxy-
cytidine as pyrimidine sources. Of interest in this regard is an 
~· coli mutant (46) which is unable to utilize thymidine, deoxyuridine 
and deoxycytidine as carbon sources because it lacks the enzymatic 
activity to cleave the deoxyribose sugar from the three nucleosides. 
This ~· coli mutant was shown to have only two per cent of the normal 
nucleosidase activity for the thymidine to thymine conversion. The 
similarity between the Neurospora uc-2 and ~· coli mutants in their 
inability to utilize the three deoxyribose nucleosides led to the con-
clusion that the uc-2 mutation acts as does the ~· coli mutation by 
causing the production of a defective deoxyribose nucleosidase enzyme. 
Further support for the conclusion that the uc-2 mutation causes 
a lack of deoxyribose pyrimidine nucleosidase activity is provided by 
work with the deoxyribose pyrimidine, 5-fluorodeoxyuridine (5-FUdR). 
In ~· coli (44) the same inducible enzyme that is responsible for the 
cleavage of thymidine also splits deoxyribose from 5-FUdR. In 
Neurospora the inhibitory effect of 5-FUdR is of longer duration in 
strains carrying the uc-2 mutation than in strains lacking it, indicat-
ing that ~ strains cannot cleave 5-FUdR. The normal growth response 
of Neurospora pyrimidine and purine mutants carrying the uc-2 mutation 
deoxyuridine 
deoxycytidine uridine 
t idine idine 
ud-1 
81 
thymine 
5-CH20H uracil 
5-for luracil 
ud-2 
deoxyribose 
uracil 
c osine 
(outer) 
Cell membrane 
Inner 
thymidine 
uc-2 / 
------+--_......--~) thymine ---~) 5-hydroxymethyluracil 
deoxyribose 
deoxyuridine 
uracil ~---------------5-formyluracil 
uridylic acid 4'-(;--- uridine 
Two mutations, uc-1 and uc-1-su, not shown above affect the control 
of the pathway. The uc-1 mutation allows the pathway that converts 
thymidine to thymine to function in germinating conidia. The uc-1-su 
mutation suppresses the action of uc-1 and restores the normal condi-
tion, the absence of the thymidine to uracil conversion in germinating 
conidia. 
Figure 3.--Proposed sites of action of mutations affecting pyrimidine 
uptake and pyrimidine salvage pathways. 
82 
to pyrimidine ribonucleosides and to purine deoxyribonucleosides and 
ribonucleosides provides evidence that the specificity of the enzyme 
altered by uc-2 is restricted to deoxyribose pyrimidine nucleosides, 
including thymidine, deoxyuridine, deoxycytidine and 5-fluorodeoxy-
uridine. 
The uc-3 mutation when introduced into pyrimidine mutant strains 
allowed utilization of 5-formyluracil and uracil, but not of thymidine, 
thymine and 5-hydroxymethyluracil (5-CH20H uracil). On the basis of 
these growth experiments the uc-3 mutation can be classified as block-
ing the 5-CH20H uracil to 5-formyluracil step in the pathway. However, 
when thymidine was administered to a uc-3 mutant strain thymine was 
accumulated in the medium while 5-CH20H uracil, the expected accumula-
tion product, could not be detected. Two possible interpretations of 
the thymine accumulation are put forward. 
l. The oxidation of the methyl group of thymine to the formyl 
level (5-formyluracil) is carried out by one enzyme. In 
this reaction 5-CH20H uracil would be an enzyme bound 
intermediate and presumably would not be formed at all 
by the mutant enzyme (uc-3). 
2. The thymine to 5-CH20H uracil to 5-formyluracil conversions 
are catalyzed by two enzymes. If the equilibrium of the 
thymine to 5-CH20H uracil conversion were to be strongly 
in favor of thymine, only small a.mounts of 5-CH20H uracil 
would accumulate even in the presence of a mutation (uc-3) 
blocking the conversion of 5-CH20H uracil to 5-formyluracil . 
Although enzymological studies of methyl group oxidation have not 
as yet produced an example of one enzyme converting a methyl group to 
the formyl oxidation state the conversion of a primary alcohol group 
to carboxylic acid by one enzyme is known (47) . Consecutive oxidations 
occur on the surface of a single enzyme without the appearance in the 
free state of the presumed aldehydic intermediate in the conversions 
of the primary alcohol groups of histidinol and uridine diphosphate 
glucose to the carboxylic acid groups of histidine and uridine 
diphosphate glucuronic acid respectively. Only a very limited amount 
of work has been reported on the enzymology of the thymine methyl 
oxidative pathway. Abbott et al . (12) administered c14 labeled thymine 
to the supernatant of a crude Neurospora extract and recovered 5-CH20H 
uracil in high yield (the equilibrium for the reaction is therefore not 
strongly in favor of thymine), but found no 5-formyluracil or other 
pyrimidine product . The enzyme carrying out the formation of 5- CH20H 
uracil required NADPH and o2 and was classified as a hydroxylase. 
Their data imply that a second enzyme is required for the formation of 
5-formyluracil . If the thymine to 5- formyluracil steps are carried 
out by one enzyme as data presented in this thesis suggest, then the 
assumption must be made that the enzyme isolated by Abbott et al . (12) 
had lost the ability to carry the substrate from the alcohol to the 
formyl oxidation state . The hypothesis of a bif'unctional enzyme carry-
ing out two oxidation steps would be strengthened if the uc-3 mutant 
should be found lacking enzymatic activity for the thymine to 5-CH20H 
uracil conversion . A conclusion which can be reached from the evidence 
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available is that the thymidine to RNA precursor pathway proceeds 
thymidine - thymine - 5-CH20H uracil - 5-formyluracil -, and that 
at least three enzymes are required for the first four steps. 
Fink (10) proposed that uracil-5-carboxylic acid is an inter-
mediate in the thymine methyl oxidative pathway. This compound would 
seem a logical intermediate of the pathway since it could be formed 
in one step from -5-formyluracil and with the release of co2 through 
the action of a decarboxylase would give uracil. However, growth 
tests with pyr mutants showed that uracil-5-carboxylic acid is the only 
one of the proposed intermediates of the pathway which is not utilized 
efficiently. In Rl!. mutant growth tests involving limiting concen-
trations of uridine an added supplement of uracil-5-carboxylic acid 
remained in the medium without loss throughout the growth period. A 
negative growth response test alone does not rule out a compound as 
an intermediate of a pathway since, for example, the organism may be 
unable to transport the compound from the medium to the site in the 
cell where it is required. Orotic acid (uracil-6-carboxylic acid) 
although an intermediate of the pyrimidine pathway is utilized in-
efficiently by Neurospora. 
Other evidence obtained in relation to uracil-5-carboxylic acid 
as a possible intermediate in the oxidative pathway is also of a 
negative nature. No mutants were found which accumulated uracil-5-
carboxylic acid nor were mutant hunts successful in finding strains 
which could utilize the compound as a pyrimidine source. In view of 
the lack of proof for a uracil-5-carboxylic acid intermediate, the 
possibility that the acid is, in fact, not an intermediate must be 
considered as likely. A one-step conversion of 5-formyluracil to 
uracil could be carried out if the formyl group were removed by a 
tetrahydrofolic acid acceptor. 
A third mutation blocking a synthetic reaction necessary for the 
incorporation of the pyrimidine ring of thymidine into RNA is uc-4. 
The uc-4 mutation when introduced into a pyrimidine mutant strain 
allowed utilization of uridine as a pyrimidine source, but not of 
thymidine, thymine, 5-CH20H uracil, 5-formyluracil or uracil. On the 
basis of the growth experiments the uc-4 mutation can be classified 
as blocking a reaction required in the incorporation of uracil into 
uridylic acid. 
Two enzymatic mechanisms are known for the conversion of uracil 
into uridine monophosphate (UMP) (13). '.Ihe first (reaction a) demon-
strated in microorganisms (48, 49) is analogous to the formation of 
orotidylic acid from orotic acid and 5-phosphoribosylpyrophosphate 
(PRPP) in the pyrimidine pathway. 
(a) uracil + PRPP ~UMP + pyrophosphate 
The second mechanism (reactions b and c) which occurs in mammalian 
tissue involves the sequential action of pyrimidine nucleoside 
phosphorylase and pyrimidine nucleoside kinase (49). 
(b) uracil + ribose-1-phosphate < ~uridine + Pi 
(c) uridine + ATP ~UMP + ADP 
Nucleoside phosphorylase reactions (reaction b) are now recognized as 
functioning in vivo for the degradation of nucleosides (44, 50). On 
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the basis of this evidence it is concluded that in Neurospora uracil 
is converted to UMP by a pyrophosphorylase enzyme (reaction a) and 
that the uc-4 mutation blocks this step. 
The pyr-1 uc-4 double mutant gave only one-third the growth of a 
pyr-1 mutant on equivalent amounts of uridine. In addition the double 
mutant was discovered to accumulate uracil in the growth medium (to a 
concentration of about one-half the molar concentration of the added 
uridine). The reduced growth of the pyr-1 uc-4 mutant was apparently 
caused by nucleosidase action on the uridine with the formation of 
uracil, which the uc-4 mutation prevents from being utilized. This 
cleavage of uridine is of interest because of the reports (17, 42, 
51, 52) that various organisms including Neurospora (with a notable 
exception being ~· coli) incorporate uniformly labeled ribonucleosides 
into nucleic acids without separation of the base and ribose moieties. 
Two basic differences exist between the experiments of McNutt 
(17), who showed that pyrimidine ribonucleosides are incorporated into 
the nucleic acids of Neurospora without breaking the nucleoside bond, 
and the work reported here, which shows that at least half of the 
added pyrimidine nucleoside is cleaved. McNutt inoculated a pyr-4 
strain of Neurospora into Fries medium (has ammonium salts) containing 
the nucleoside while in the work reported here a pyr-1 uc-4 double 
mutant was inoculated into Westergaard-Mitchell medium (no ammonium 
salts) containing the nucleoside. The possibility exists that a 
secondary action of the uc-4 mutation could induce the production of a 
uridine nucleosidase enzyme and cause the cleavage of uridine. It is 
believed more likely that the Westergaard-Mitchell medium is responsible 
(at least indirectly) for the increased nucleosidase action since this 
medium also has a large effect on the efficiency of utilization of 
intermediates of the thymidine to RNA precursor pathway. 
Mutations affecting pyrimidine transport 
It now appears likely that for most physiologically important 
substrates the fungal cell possesses special transport systems which 
allow rapid entry into the cell (53). The number of such mechanisms 
is probably not large since the transport systems thus far discovered 
have a broad specificity. In yeast, the only fungus in which trans-
port has been studied with any intensity, there are known about fif'teen 
to twenty transport systems; three or four for inorganic ions, three 
for sugars, four or five for amino acids, three for organic acids and 
a small number for nucleotides and growth factors. These systems are 
not normally present, but are induced in the presence of a specific 
substrate. The mechanisms by which solutes penetrate the membrane are 
not well understood, although many models have been proposed (53, 54). 
The kinetics of transport can be explained in most cases by assuming 
that the substrate must form a chemically specific complex with a 
receptor site in the membrane in order for transport to occur. It is 
hypothesized that this complex or a complex formed by transfer of the 
substrate to a second carrier moves across the membrane and releases 
the substrate on the other face of the membrane. 
Mutants which are defective in the uptake of a given class of 
compounds (transport negative mutants) have been very useful in the 
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study of various transport systems. In bacteria two methods have been 
used to select for transport negative mutants. The first method in-
volves selecting for resistance to various growth inhibitors, for 
instance some canavanine resistant mutants were found to be defective 
in the transport of canavanine and the structually related amino acid, 
arginine (55). The second method takes advantage of the expected 
absence of growth ·of specific auxotrophs which have undergone a 
mutational loss of the transport mechanism specific for their re-
quired compound (56, 57). For example, from a histidineless strain 
(his-) of~· ~a double mutant was selected (his- histidine trans-
port negative) which required 25 times the concentration of histidine 
in the external medium to equal the growth rate of the parent strain. 
The double mutant was shown to lack the ability to accumulate histidine 
in the cell. 
The method described here to .select for mutations blocking 
specific reactions in the pyrimidine salvage pathway is essentially the 
procedure used in bacteria to isolate transport mutants from an aux.o-
troph. When pyr mutant conidia were irradiated and selection was made 
for isolates which could not utilize a given pyrimidine two types of 
mutants were possible: those mutants defective in an enzyme necessary 
for the conversion of the pyrimidine into nucleic acid and those lack-
ing the ability to transport the pyrimidine into the cell . These mutant 
hunts yielded several Neurospora isolates carrying new mutations which 
prevent the utilization of various pyrimidines . Evidence has been 
discussed to show that three of these mutations, uc-2, uc-3 and uc-4, 
cause defective enzymes in the pyrimidine salvage pathways. Data 
gathered from strains carrying another three mutations, uc-5, ud-1 and 
ud-2, can be most simply interpreted in terms of these mutations dis-
rupting pyrimidine transport mechanisms. 
From a pyr-1 Neurospora strain was isolated a double mutant, 
pyr-1 uc-5, which was unable to utilize the free pyrimidine bases, 
thymine, 5-CH20H ·uracil, 5-formyluracil and uracil, although it did 
utilize in a normal manner the ribose and deoxyribose pyrimidines, 
uridine, cytidine, deoxyuridine and thymidine. The uc-5 mutation 
cannot be affecting an enzyme in the synthetic pathways converting 
deoxyribose pyrimidine nucleosides to RNA pyrimidines since the initial 
compounds of the pathway, thymidine and deoxyuridine, are utilized 
while intermediates which normally arise from these two compounds are 
not metabolized. A hypothesis which explains the growth response of 
the pyr-1 uc-5 double mutant is that Neurospora possesses one transport 
system for pyrimidine nucleosides and a second system for pyrimidine 
bases; the latter system is prevented from functioning by the uc-5 
mutation (figure 3). 
Support for the hypothesis that Neurospora has two transport 
systems to carry pyrimidines into the cell was obtained from experi-
ments with a second double mutant, Pyr-1 ud-1, isolated because of 
its inability to utilize uridine. This double mutant behaves in an 
opposite manner to the pyr-1 uc-5 mutant in that the ~ carrying 
double mutant cannot utilize the ribose and deoxyribose pyrimidines 
(uridine, cytidine, deoxyuridine and thymidine), although it can use 
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the pyrimidine bases (uracil, thymine, etc.) in a normal manner. Again 
it is difficult to propose a single enzyme deficiency in the synthetic 
pathway which could produce the growth responses given by the py:--1 
ud-1 mutant. The most plausible explanation is that the ud-1 mutation 
prevents transport of pyrimidine nucleosides into the cell, but does 
not affect pyrimidine base transport. Verification that uc-5 and ~ 
mutations prevent pyrimidine transport would be the demonstration that 
strains carrying these mutations possess the normal enzyme complement 
for utilization of the pyrimidine bases and nucleosides. 
Of interest in relation to pyrimidine transport negative mutants 
in Neurospora was a report of cytidine uptake by ~. coli ( 58). The 
transport of cytidine into the cell was competitively inhibited by 
the presence of uridine, thymidine and adenosine, but not by free 
purine or pyrimidine bases. In a similar study the uptake of adenosine 
by the E. coli cell was competitively inhibited by pyrimidine nucleo-
sides (uridine, cytidine, deoxyuridine and thymidine) and by several 
purine nucleosides ( 59). Guanosine and the purine and pyrimidine 
bases gave little competition to adenosine uptake. In general the 
results of ~.coli suggest the presence of a transport element common 
to purine and pyrimidine nucleosides, but which shows little affinity 
for free nucleic acid bases. Information as to whether the Neurospora 
uc-5 and ud-1 mutations affect purine transport was not obtained, but 
the Neurospora and~· coli systems are similar in that they both must 
possess two pyrimidine transport systems, one for the bases and the 
other for the nucleosides. 
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Only a few transport negative Neurospora mutants have been 
reported. Both Lester (60) and Stadler (61) isolated Neurospora mu-
tants which were resistant to 4-methyl tryptophan (mtr mutants). The 
germinating conidia of mtr strains had a greatly reduced ability to 
take up methyl tryptophan, tryptophan, phenylalanine, tyrosine and 
several other amino acids . The action of the mtr mutant is consistent 
with the evidence which shows that Neurospora has a small number of 
amino acid transport systems, each responsible for the transport of 
several amino acids (62). Crocken and Tatum (63) have investigated 
sorbose transport in Neurospora and indicate that some sorbose 
resistant Neurospora mutants may be defective in the ability to take 
up sorbose and related sugars from the medium. 
A limited number of Neurospora mutations have been studied, whose 
actions affect the permeability of a much wider range of compounds 
than can be explained by the specificity of most transport systems. 
St. Lawrence et al. (64) have characterized a mutant, mod-5,in which 
the germinating conidia initially give enhanced uptake of all the 
amino acids and of small peptides. Davis and Zimmerman (43) reported 
a mutant, UM-300, that has deficient uptake of arginine, lysine, 
unrelated amino acids, and uridine, but at least with regard to 
arginine the difficulty of uptake is conditional on the presence of 
ammonium in the medium. The ud-2 mutant discovered here, which cannot 
utilize any pyrimidine in a medium containing ammonium salts but does 
use pyrimidines when the medium lacks ammonium salts may well be a 
mutant of the UM-300 type . The primary action of such mutations as 
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mod-5, UM-300 and ud-2 may not be on a specific transport system 
itself, but on a cell membrane barrier to permeability or a step in 
transport common to many specific transport systems. 
Mutations affecting the regulation of the thymidine to RNA precursor 
pathway 
Two mutati~~s, uc-1 and uc-1-su influence the regulation of the 
thymidine to RNA precursor pathway shown in figure 3. Strains carry-
ing the uc-1 mutation were isolated as colonies which appeared on 
thymidine plus thymine supplemented sorbose plates which had been 
inoculated with UV irradiated pyr-4 conidia. Conidia of pyr-4 in-
oculated into medium containing only thymidine, thymine or 5-CH20H 
uracil as a pyrimidine source will not grow. These same compounds 
are efficiently utilized when a normal pyrimidine source such as 
uridine is added to the medium to promote some initial mycelial growth. 
The presence of the uc-1 mutation allows pyrimidine mutants to grow 
normally when the pyrimidine requirement is met only by thymidine, 
thymine or 5-CH20H uracil. 
The uc-1-su mutation suppresses the action of uc-1. (In figure 4 
is given the parent strain from which the suppressor mutant was 
isolated. Also given are the origins of the other isolated mutants.) 
A pyr-4 uc-1 uc-1-su triple mutant behaves as does a pyr-4 mutant in 
that neither will grow when thymidine, thymine and 5-CH20H uracil are 
the sole pyrimidine sources. 
The pyr-4 ~ double mutant was of superficial interest because 
the two mutations, pyr-4 blocking the pyrimidine synthetic pathway and 
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pyr-4 a (3660l) 
y-~ 
X pyr-4 uc-1 a pyr-4 uc-2 a X 4A (wild) 
'\ -- -:!/ -4~ (wild) 
pyr-4 uc-1 ~ pyr-4 uc-2 
lN 
pyr-4 uc-1 uc-1-su pyr-4 uc-l uc-2 II and III 
25~ (wild) X pyr-4 uc-1 uc-3 A 
pyr-4 ~ uc~ 3 A X PF-1 a 
-- --1 -
uc-2 a X Pyr- 4 uc-l A 
--1 --
pyr-4 uc-l uc-2 I 
pyr-l uc-3 
pyr-1 ~ (H263) 
lN 
4A (wild) X pyr-1 uc-4 a l -- pyr-1 uc-5 a X 4A (wild) --1-
pyr-l uc-4 and uc-4 pyr-l uc-5 and uc-5 
4A (wild) X pyr-1 ud-1 a 1 -- pyr-l ud-2 a X 4A (wild) -- l -
pyr-1 ud-1 and ud-1 pyr-l ud-2 and ud-2 
Figure 4.--0rigins of uracil (~) and uridine (ud) mutants. All mutants 
reported were induced by UV in strains carrying either the 
pyr-4 or pyr-1 mutation. Strains carrying new mutations 
were crossed to either wild type 4~ or 25~ and mutant segre-
gants were reisolated. Crosses were also made between 
mutant strains to provide segregants carrying the mutations 
~n new combinations. 
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uc-1 which allows the induction of the thymidine to RNA precursor 
pathway in germinating conidia, give the same phenotype (no growth 
on minimal, a response to thymine or thymidine) as would be expected 
of a thymine mutant. Although looked for, thymine mutants, which have 
a defective thymidylate synthetase enzyme, have never been recovered 
in Neurospora. Since Neurospora possesses no alternate means of form-
ing thymidylic acid i.e., a thymidine phosphorylating enzyme, and 
because thymidylic acid is unable to penetrate the cell wall thymine 
mutants are irreparable. 
The isolation of mutants blocking synthetic reactions involved in 
the utilization of thymidine (uc-2, uc-3 and uc-4) and of mutants 
affecting pyrimidine transport systems (uc-5 and ud-1) emphasizes the 
role of the ~gene in controlling one or more of these reactions. 
To answer the question of what kind of control the uc-1 gene imposes 
(feedback inhibition, repression or some less understood control) the 
reaction or reactions controlled by uc-1 must be known. In answer to 
the latter question the growth response tests show only that the 
enzyme(s) necessary for the conversion of 5-CH20H uracil and/or 5-
formyluracil to uracil are repressed, or possibly are present and 
subject to an inhibitor, in the germinating conidia of strains not 
carrying the uc-1 mutation. These growth tests provide no clue as to 
whether enzymatic steps before 5-formyluracil in the pathway are subject 
to control by the uc-1 gene. Clearly studies of the thymidine to RNA 
precursor pathway enzymes and of pyrimidine transport systems in uc-1 
and normal strains are needed. However, available evidence does permit 
at least a superficial comparison of the uc-1 mutant with regulatory 
mutants in more defined systems. 
The presence of a series of mutants affecting both the conversion 
of thymidine to an RNA precursor and pyrimidine transport systems 
initially suggests the possibility that these reactions are controlled 
by a method similar to that described by Jacob and Monad (65) for the 
lactose operon in~· coli. In such a comparison the uc-1 mutation 
could be regarded as analogous to the i mutation in ~· coli permitting 
the constitutive synthesis of enzymes which normally must be induced. 
However, two lines of evidence indicate that this new group of 
Neurospora mutants is not part of an operon. First, neither pyrimidine 
transport system (one for pyrimidine bases and another for pyrimidine 
nucleosides) appears to be controlled by the uc-1 gene. Conidia of 
strains lacking the uc-1 mutation cannot utilize thymine and thymidine, 
but can use uracil and uridine. Therefore, the pyrimidine transport 
systems are present under conditions where synthesis of one or more of 
the enzymes of the thymidine to RNA precursor pathway is prevented. 
Second, it should be noted that genes governing synthesis and induci-
bility in the ~· coli system are closely linked while those in the 
Neurospora system are for the most part scattered. 
The regulatory uc-1 locus is linked, although not closely to the 
pyr-4 locus on chromosome II while uc-2 (deoxyribose pyrimidine 
nucleosidase) is linked to the mating type locus on chromosome I as is 
uc-4 (uracil to uridylic acid conversion). The uc-5 locus (pyrimidine 
base transport) is linked to pyr-l on chromosome IV. The linkages . of 
uc-3 (thymine to 5-formyluracil conversion), ud-1 (pyrimidine nucleoside 
~~ ~
transport), ~ (all pyrimidine transport in anunonium medium) and 
uc-1-su (suppressor of uc-1) loci are not known. There was no evidence 
that uc-3 is linked to a mating type, pyr-4 or Pyr-l locus as were some 
previously mentioned mutations. Neither was there evidence for the 
linkage of ud-1 and ud-2 to a Pyr-1 or mating type locus. It should be 
mentioned that a mutant was not found for the enzyme that converts 
5-formyluracil to uracil. 
The linkage data, in general, fit the pattern in Neurospora and 
higher organisms where only a limited number of cases are known of 
genes belonging to the same biosynthetic pathway being adjacent to one 
another on the genetic map. Several systems have been investigated in 
Neurospora in which genes producing two or more enzymatic functions of 
the same biochemical pathway map at the same locus (66, 67). Some of 
these loci now appear to produce one enzyme with two enzymatic activi-
ties, such as trypt-3 (tryptophan synthetase) and pyr-3 (carbamyl 
synthetase and aspartate transcarbamylase). The hist-3 locus in 
Neurospora in which three enzymatic activities are located is probably 
one of the best cases for an operon in an organism other than a bacte-
rium. The possibility exists that the uc-2 and uc-4 loci of the thymi-
dine to RNA precursor pathway might be closely linked, since on the 
basis of tests with a limited number of ascospores both uc-2 and uc-4 
showed close linkage to the mating type gene. 
Horowitz et al. (68, 69) have described three unlinked genes, ~' 
ty-1 and ty-2, controlling the synthesis of tyrosinase in Neurospora 
crassa. The ! gene has a structure determining role in the synthesis 
of the enzyme while ty-1 and ty-2 influence the synthesis indirectly 
through their control of an inductive mechanism that operates on the 
enzyme. Several similarities between the tyrosinase and thymidine to 
RNA precursor pathway systems bear mentioning. 
1. Both the ty genes and the uc-1 gene are not linked to 
the genes whose products they control. 
2. Both tyrosinase and the enzymes of the thymidine to RNA 
precursor pathway are nonessential enzymes. 
3. Both systems respond to a starvation medium. Tyrosinase 
production is constitutive in a low sulfate or nitrogen 
medium, and the thymidine to RNA precursor pathway 
functions most efficiently in a nitrogen starved medium. 
4. Tyrosinase production in constitutive strains is greatest 
in four day old mycelia. This age mycelia is likely the 
period of greatest thymidine to RNA precursor enzyme 
synthesis since the degraded nucleic acids released by 
death of cells could be expected to induce the system. 
However, the ty mutations and uc-1 seem to act in an almost opposite 
manner. The ty mutations prevent the constitutive production of tyro-
sinase while the uc-1 mutation makes constitutive or at least allows 
the induction in germinating conidia of the enzymes of the thymidine 
pathway. The biochemical defect of ty-1 and ty-2 is regarded as either 
a deficiency in the production of inducer or an excessive production of 
repressor. If the action of the uc-1 gene is to be regarded as similar 
to that of the !_l genes then one must assume that the uc-1 mutation 
causes increased production of inducer or causes a defective repressor. 
Preliminary experiments have revealed other evidence relating to 
control of pyrimidine salvage pathways. When a pyr mutant is grown in 
a medium containing a growth limiting concentration of uridine plus an 
added thymine supplement the thymine concentration does not begin to 
drop until the mycelial pad reaches a weight at which growth would have 
stopped if only the uridine had been present. A second observation was 
that a pyr-4 uc-1 double mutant (which utilizes thymidine , thymine and 
5-CH20H uracil as sole pyrimidine sources just as efficiently as the 
parent pyr-4 strain uses uridine) utilizes uridine only about one-half 
as efficiently as a pyr-4 strain . These results show that the 
reaction(s) by which uridine is utilized and the thymidine to RNA pre-
cursor pathway do not function independent of one another. 
The control of one pathway by another could be brought about if, 
for example, uridine monophosphate (a product of the uridine kinase 
reaction and the end product of the thymidine to RNA precursor pathway) 
has an end product feedback inhibition action on an enzyme of the 
thymidine to RNA precursor pathway. The uc-1 mutation might then be 
regarded as a mutation causing the production of a uridine kinase 
enzyme of reduced activity. A mutation acting as proposed would 
directly affect uridine utilization and indirectly affect the thymi -
dine to RNA precursor pathway . 
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